{"id":83,"date":"2023-03-03T19:38:53","date_gmt":"2023-03-03T10:38:53","guid":{"rendered":"https:\/\/helios.huhp.hokudai.ac.jp\/crmic\/?page_id=83"},"modified":"2026-05-08T13:21:58","modified_gmt":"2026-05-08T04:21:58","slug":"%e5%ad%a6%e4%bc%9a%e3%83%bb%e8%ab%96%e6%96%87%e7%99%ba%e8%a1%a8","status":"publish","type":"page","link":"https:\/\/helios.huhp.hokudai.ac.jp\/crmic\/center\/achievements\/%e5%ad%a6%e4%bc%9a%e3%83%bb%e8%ab%96%e6%96%87%e7%99%ba%e8%a1%a8\/","title":{"rendered":"\u5b66\u4f1a\u30fb\u8ad6\u6587\u767a\u8868"},"content":{"rendered":"\n

2025\u5e74\u5ea6<\/h2>\n\n\n\n

1. \u8ad6\u6587\u30fb\u8457\u66f8<\/h3>\n\n\n\n
\n
\n\n \n\n \n\n \n\n <\/colgroup>\n\n \n\n
No<\/th>\n\n \u5b9f\u7e3e<\/th>\n\n <\/tr>\n\n <\/thead>\n\n
1<\/th>Tarisawa M, Matsushima M, Kudo A, Nomura T, Uwatoko H, Shirai S, Takahashi-Iwata I, Sakushima K<\/span>, Yaguchi H, Yokota I<\/span>, Nishimoto N, Sawada J, Matsuoka T, Uesugi H, Minami N, Sako K, Takei A, Hisahara S, Kanatani Y, Tamakoshi A, Sato N<\/span>, Yabe I\uff1a Trends in Invasive Interventions and Risk Factors for Early Critical Events in Multiple System Atrophy., Cerebellum, 24(5):152, doi: 10.1007\/s12311-025-01905-z<\/td><\/tr>\n
2<\/th>Krishna R, Jonker AH, Morel T, Sakushima K<\/span>, Pasmooij AMG, O’Connor D\uff1aIRDiRC perspectives on the application of digital biomarkers in therapeutic development for rare diseases., Nat Rev Drug Discov., 24(4):233-234, doi: 10.1038\/d41573-024-00196-z<\/td><\/tr>\n
3<\/th>Goudarzi H, Onozawa M, Ito YM<\/span>, Takahashi M\uff1aClustering of students in pre-clinical medical education and identification of academic performance profiles: does online education work for all medical students?, BMC Med Educ., 26(1):396, 10.1186\/s12909-026-08737-3<\/td><\/tr>\n
4<\/th>Hishikawa T, Murai S, Ito YM<\/span>, Funaki T, Fujimura M, Hamano E, Kataoka H, Takahashi JC, Endo H, Inaji M, Nariai T, Honjo K, Osato T, Miyawaki S, Saito N<\/span>, Isozaki M, Kikuta K, Machida T, Mase M, Yamaguchi K, Kawamata T, Sato N, Yamamoto S, Hori E, Kashiwazaki D, Miyamoto S, Kuroda S\uff1aThe AMORE Score for Predicting the 5-Year Risk of Hemorrhagic Stroke in Asymptomatic Moyamoya Disease., Cerebrovasc Dis., Online ahead of print., 10.1159\/000550273<\/td><\/tr>\n
5<\/th>Kobayashi T, Yamada K, Yamaguchi S, Ishibashi H, Arai T, Morita Y, Ito YM<\/span>, Ohe T, Nakagawa R\uff1aSubjective slow walking speed is associated with locomotive syndrome severity in 34,935 adults undergoing medical checkups., Sci Rep., 16(1):5189, 10.1038\/s41598-026-36083-3<\/td><\/tr>\n
6<\/th>Kobayashi T, Yamada K, Yamaguchi S, Ishibashi H, Arai T, Morita Y, Ito YM<\/span>, Morimoto T, Ohe T, Nakagawa R\uff1aBodyweight increase since early adulthood as a risk factor for mobility decline: a 7-year longitudinal study of 10,316 Japanese adults aged \u2265 40 years., Arch Public Health., 84(1):29, 10.1186\/s13690-025-01829-4<\/td><\/tr>\n
7<\/th>Naito Z, Poudel S, Ishido K, Kurashima Y, Ito YM<\/span>, Hirano S\uff1aDevelopment of Nontechnical Skills Assessment Tool and The Validation Study for Laparoscopic Inguinal Hernia Repair., J Surg Educ., 83(2):103799, 10.1016\/j.jsurg.2025.103799<\/td><\/tr>\n
8<\/th>Fukataki Y, Hayashi W, Nishimoto N<\/span>, Ito YM<\/span>\uff1aDeveloping artificial intelligence tools for institutional review board pre-review: A pilot study on ChatGPT’s accuracy and reproducibility., PLOS Digit Health., 4(6):e0000695, 10.1371\/journal.pdig.0000695<\/td><\/tr>\n
9<\/th>Yoshimura M, Takahashi K, Ito YM<\/span>, Sumi N\uff1aDischarge Readiness Assessment in Patients With Heart Failure by Registered Nurses Working in the Cardiovascular Ward: A Longitudinal Study of the Utility of the Care Transitions Scale for Patients With Heart Failure., J Cardiovasc Nurs., 41(2):111-119, 10.1097\/JCN.0000000000001229<\/td><\/tr>\n
10<\/th>Tsutsumi T, Kawaguchi T, Fujii H, Kamada Y, Suzuki Y, Sawada K, Tatsuta M, Maeshiro T, Tobita H, Akahane T, Hasebe C, Kawanaka M, Kessoku T, Eguchi Y, Syokita H, Nakajima A, Kamada T, Yoshiji H, Sakugawa H, Morishita A, Masaki T, Ohmura T, Watanabe T, Yoda Y, Enomoto N, Ono M, Fuyama K, Okada K<\/span>, Nishimoto N<\/span>, Ito YM<\/span>, Takahashi H, Charlton MR, Rinella ME, Sumida Y\uff1aLow HDL cholesterol levels in women and hypertriglyceridemia in men: predictors of MASLD onset in individuals without steatosis., J Gastroenterol., 60(7):891-904, 10.1007\/s00535-025-02242-y<\/td><\/tr>\n
11<\/th>Masunaga T, Suenaga T, Matsushima S, Hashimoto T, Takada S, Noda E, Fumoto Y, Hata S, Yokota T<\/span>, Kinugawa S\uff1aReduction in Acetylation of Superoxide Dismutase 2 in Skeletal Muscle Improves Exercise Capacity in Mice With Heart Failure , J Cachexia Sarcopenia Muscle, 16:e13850., 10.1002\/jcsm.13850<\/td><\/tr>\n
12<\/th>Kubo T, Sugiura K, Tokita Y, Takano H, Takamisawa I, Takayama M, Doi YL, Minami Y, Shirotani S, Ebato M, Tsujiuchi M, Nabeta T, Inomata T, Kato T, Okamoto R, Dohi K, Takei Y, Chikamori T, Watanabe E, Furugen A, Doi H, Akita K, Maekawa Y, Ogimoto A, Tada N, Yokota T<\/span>, Ikeda S, Yamaguchi O, Izumiya Y, Shibata A, Takashio S, Tsujita K, Maejima Y, Fujino N, Nomura A, Akasaki Y, Higuchi K, Fujita S, Hoshiga M, Shiraishi Y, Ieda M, Miyamoto Y, Kitaoka H\uff1aContemporary clinical characteristics and management patterns in hypertrophic cardiomyopathy: insights from baseline enrolment data in a nationwide prospective Japanese registry , Heart, 111:885-892, 10.1136\/heartjnl-2024-324811<\/td><\/tr>\n
13<\/th>Kinota N, Abo D, Morita R, Yamasaki K, Fujii T, Kato D, Kimura T, Sakuhara Y, Okada K<\/span>, Yokota I<\/span>, Orimo T, Kakisaka T, Nakamura T, Hirano S, Minowa K, Kudo K\uff1aImprovement of hypoalbuminemia and Hepatic reserve after stent placement for post-surgical portal vein stenosis., J Vasc Interv Radiol, 36(4):616-624.e2, 10.1016\/j.jvir.2024.12.005<\/td><\/tr>\n
14<\/th>Nakayama K, Kaneko N, Hishimura N, Yamaguchi T, Morikawa S, Yokota I<\/span>, Kamasaki H, Nagasaki K, Hasegawa Y, Nakamura A\uff1aAdiposity rebound and body mass index in Japanese patients with congenital hypothyroidism, Clin Pediatr Endocrinol, 34(2):121-130, 10.1297\/cpe.2024-0075<\/td><\/tr>\n
15<\/th>Fuyama K, Sakamaki K, Uemura K, Yokota I<\/span>\uff1aImpact of correlation structure on sample size requirements of statistical methods for multiple binary outcomes: A simulation study., Clin Trials, 22(3):301-311, 10.1177\/17407745241304706<\/td><\/tr>\n
16<\/th>Hirose K, Poudel S, Murakami S, Kurashima Y, Sato N, Tojima H, Yokota I<\/span>, Okada K<\/span>, Shichinohe T, Hirano S\uff1aHow confident are the general surgeons in Hokkaido region in performing essential trauma skills: a cross-sectional questionnaire survey., World J Emerg Surg, 20(1):49, 10.1186\/s13017-025-00623-5<\/td><\/tr>\n
17<\/th>Tatsuta D, Nakao M, Nagai T, Mizuguchi Y, Yokota I<\/span>, Koya T, Tada A, Ishizaka S, George F, Kato Y, Imagawa S, Motoi K, Tokuda Y, Takahashi M, Matsumoto J, Machida M, Okamoto H, Saito T, Anzai T; ELMSTAT-HF Investigators\uff1aClinical phenotyping and treatment response in patients with chronic heart failure., JACC Adv, 4(8):101972, 10.1016\/j.jacadv.2025.101972<\/td><\/tr>\n
18<\/th>Shima H, Tsujino I, Nakaya T, Nakamura J, Igarashi-Sugimoto A, Sato T, Watanabe T, Ohira H, Hisada R, Kato M, Tsuneta S, Yokota I<\/span>, Konno S\uff1aRight ventricular dysfunction in lung disease\/hypoxia-associated pulmonary hypertension., J Am Heart Assoc, 14(16):e042186, 10.1161\/JAHA.125.042186<\/td><\/tr>\n
19<\/th>Li H, Hao W, Maeda E, Kumazawa Y, Takahashi K, Tanaka T, Yokota I<\/span>, Terada Y, Nomura K, Okada H, Tamakoshi A\uff1aPhysical activity, sedentary time and sperm DNA fragmentation index in healthy Japanese men., Reprod Biomed Online, 51(4):105015, 10.1016\/j.rbmo.2025.105015<\/td><\/tr>\n
20<\/th>Igarashi-Sugimoto A, Tsujino I, Shima H, Nakamura J, Nakaya T, Sato T, Watanabe T, Ohira H, Takamura K, Otsuka N, Ishizu A, Iwasaki S, Tanei Z, Tanino M, Taniguchi K, Tanaka S, Yokota I<\/span>, Konno S\uff1aPathological features of pulmonary vasculopathy in interstitial lung disease-associated pulmonary hypertension., Respir Med, 248:108395, 10.1016\/j.rmed.2025.108395<\/td><\/tr>\n
21<\/th>Oshino T, Shimizu H, Sato M, Nishida M, Horie T, Tsuneta S, Kato F, Hosoda M, Yokota I<\/span>, Kudo K, Takahashi M\uff1aImpact of breast tumor size discrepancy between contrast-enhanced and conventional ultrasonography on axillary node metastasis: a retrospective cohort study, BMC Cancer, 25(1):1718, 10.1186\/s12885-025-15167-9<\/td><\/tr>\n
22<\/th>Takahashi K, Okada K<\/span>, Tanaka S, Yokota I<\/span>\uff1aAdaptive constrained weighted estimation for incorporating multiple external information sources, Pharm Stat, 25(1):e70059, 10.1002\/pst.70059<\/td><\/tr>\n
23<\/th>Saito J, Muto M, Tada M, Yokota I<\/span>, Kamiya S, Numata Y, Sasaki H, Hashizume T, Iwata K, Asano M, Wakasa S\uff1aDiffusion-weighted whole-body magnetic resonance imaging with background body signal suppression for differentiating infectious from non-infectious aortitis., Diagnostics (Basel), 16(2):225, 10.3390\/diagnostics16020225<\/td><\/tr>\n
24<\/th>Hafermann L, Yokota I<\/span>, Kalski L, Wolfarth B, Herrmann C.\uff1aMultiple linear regression modeling with values below a lower limit of quantification – a statistical method comparison., BMC Med Res Methodol, 26(1):18, 10.1186\/s12874-026-02770-y<\/td><\/tr>\n
25<\/th>Maeda E, Konishi S, Sunohara S, Jwa SC, Yokota I<\/span>, Boivin J, Nomura K, Tamakoshi A\uff1aPrevalence of infertility among nationally representative women in Japan: A cross-sectional survey using a two-stage stratified systematic sampling design., Public Health, 251:106092, 10.1016\/j.puhe.2025.106092<\/td><\/tr>\n
26<\/th>Horiguchi G, Yokota I<\/span>, Teramukai S\uff1aBayesian power-based sample size determination for single-arm clinical trials with time-to-event endpoints., Pharm Stat, 25(2):e70087, 10.1002\/pst.70087<\/td><\/tr>\n
27<\/th>Wataki H, Seposo XT, Uttajug A, Anzai T, Yokota I<\/span>, Ueda K, Yonemoto N, Tahara Y, Matoba T, Ikeda T; Japanese Circulation Society with Resuscitation Science Study (JCS-ReSS) Investigators\uff1aImpact of snowfall on ambulance response times to out-of-hospital cardiac arrest\u3000- nationally-representative population-based registry analysis, 2009-2019., Circ Rep, 8(3):479-485., 10.1253\/circrep.CR-25-0129<\/td><\/tr>\n
28<\/th>Shizawa Y, Goto T, Nakajima M, Unoki T, Nakamura K, Yokota I<\/span>\uff1aSimple risk score (MV-SoLdHARP) for intensive care unit readmission or in-hospital death among surgical intensive care unit patients: Derivation and internal validation using a Japanese nationwide inpatient database., Surgery, 194:110143, 10.1016\/j.surg.2026.110143<\/td><\/tr>\n
29<\/th>Uchinami Y, Fujita N, Hoshino K, Kubo Y, Yagi Y, Shoji M, Yokota I<\/span>, Morimoto Y\uff1aEffectiveness of McGRATH MAC video laryngoscopy for first-attempt intubation by anesthesia trainees in infants: a randomized controlled trial., Anesth Analg, Online ahead of print, 10.1213\/ANE.0000000000007952<\/td><\/tr>\n
30<\/th>Okamoto K, Hijioka S, Kobayashi N, Imaoka H, Hara K, Takeuchi S, Fujimori N, Sudo K, Horiguchi S, Takada R, Ono T, Terashima T, Shioji K, Kondo S, Furukawa T, Ueno M, Tsumura H, Tobimatsu K, Doi T, Asama H, Kawaguchi S, Kitano Y, Maeda O, Kobayashi S, Arima S, Unno M, Ohno E, Kawata K, Ashida R, Naganuma A, Murohisa G, Yamada R, Satake H, Kodama Y, Yokota I<\/span>, Okuyama H, Shimizu S, Morizane C, Ueno M, Nagano H, Furuse J; Japan Oncology Network in Hepatobiliary and Pancreas\uff1aEfficacy and safety of peptide radionuclide therapy with 177Lu-DOTATATE in Japanese patients with advanced neuroendocrine neoplasm: a multicenter retrospective study (JON2203-N)., J Gastroenterol, Online ahead of print, 10.1007\/s00535-026-02396-3<\/td><\/tr>\n
31<\/th>Takayuki Toki, Kazuyuki Mizunoya, Takashi Soejima, Yasunori Yagi, Naoko Nakamine, Yusuke Itosu, Ryo Takagi<\/span>, Isao Yokota<\/span>, Yuji Morimoto\uff1aReproducibility of glycocheck measurements in patients under general anesthesia with muscle relaxants: A prospective observational study , Journal of Clinical Monitoring and Computing , 39(6), 1169\u20131177, 10.1007\/s10877-025-01322-x<\/td><\/tr>\n
32<\/th>Takeo Nitta, Yuma Ebihara, Ryo Takagi<\/span>, Hironobu Takano, Saseem Poudel, Hideyuki Wada, Toshiaki Shichinohe, Satoshi Hirano\uff1aMinimally invasive abdominal and left thoracic approach (MALTA) for Siewert type II esophagogastric junction adenocarcinoma: A retrospective cohort study of perioperative and oncologic outcomes. , Surgical endoscopy , 40(1):586-597, 10.1007\/s00464-025-12320-0 <\/td><\/tr>\n
33<\/th>Shinya Otsuka, Haruhiko Shiiya, Ryo Takagi<\/span>, Kazufumi Okada, Akihiro Sasaki, Kazuto Ohtaka, Aki Fujiwara-Kuroda, Hideki Ujiie, Masato Aragaki, Tatsuya Kato\uff1aPreoperative brain natriuretic peptide levels are associated with postoperative all-cause mortality in patients with lung cancer , Surgery Today , published online, 10.1007\/s00595-025-03108-9<\/td><\/tr>\n
34<\/th>Soichiro Oda, Kazumichi Kawakubo, Ryo Takagi<\/span>, Katsuma Nakajima, Shoya Shiratori, Hiroki Yonemura, Shunichiro, Nozawa Ryo, Sugiura Masatsugu, Ohara Masaki, Kuwatani, Naoya Sakamoto\uff1aEffect of Skeletal Muscle Mass Loss on Outcomes of Patients With Intraductal Papillary Mucinous Neoplasm. , Pancreas, in press, 10.1097\/MPA.0000000000002628 <\/td><\/tr>\n
35<\/th>Hideki Fujii, Yoshihiro Kamada, Yuichiro Suzuki, Koji Sawada, Miwa Tatsuta, Tatsuji Maeshiro, Hiroshi Tobita, Tsubasa Tsutsumi, Takemi Akahane, Chitomi Hasebe, Miwa Kawanaka, Takaomi Kessoku, Yuichiro Eguchi, Hayashi Syokita, Atsushi Nakajima, Tomoari Kamada, Hitoshi Yoshiji, Takumi Kawaguchi, Hiroshi Sakugawa, Asahiro Morishita, Tsutomu Masaki, Takumi Ohmura, Toshio Watanabe, Yoshioki Yoda, Nobuyuki Enomoto, Masafumi Ono, Kanako Fuyama, Kazufumi Okada, Naoki Nishimoto<\/span>, Yoichi M. Ito<\/span>, Hirokazu Takahashi, Yoshio Sumida\uff1aAlcohol Intake and Cardiometabolic Risk Factors Are Independently Associated With a Higher AST\/Platelet Ratio Index in Obese Males, Liver International Communications, e70010, 10.1002\/lci2.70010<\/td><\/tr>\n
36<\/th>Fujiwara K, Morita S, Hoshino K, Takeda H, Komatsuda K, Kahata K<\/span>, Nakamaru Y, Homma A\uff1aVEXAS syndrome with cochleovestibular involvement., Auris Nasus Larynx. , 2026 Feb;53(1):70-75. , doi: 10.1016\/j.anl.2025.12.010.<\/td><\/tr>\n
37<\/th>Shiratori S, Suto K, Hasegawa Y, Ara T, Matsukawa T, Goto H, Onozawa M, Nakagawa M, Kahata K<\/span>, Hidaka D, Ogasawara R, Okada K, Sugita J, Kakinoki Y, Ota S, Hashimoto D, Teshima T\uff1aSafety and Efficacy of Graft-versus-Host Disease Prophylaxis with Mini-Dose Methotrexate in Umbilical Cord Blood Transplantation: An NJHSG-CBT18 Observational Study., Transplant Cell Ther. , 2026 Mar;32(3):339.e1-339.e9. , doi: 10.1016\/j.jtct.2025.10.035. <\/td><\/tr>\n
38<\/th>Katsuhisa Yamada, Takahiko Hyakumachi, Terufumi Kokabu, Kenichiro Maeda<\/span>, Toshiyuki Isoe<\/span>, Khin Khin Tha, Yoichi M. Ito<\/span>, Takashi Ohnishi, Tsutomu Endo, Daisuke Ukeba, Hiroyuki Tachi, Yuichiro Abe, Yoko Ishikawa, Nozomi Yokota<\/span>, Takashi Miyakoshi<\/span>, Osamu Sugita<\/span>, Norihiro Sato<\/span>, Norimasa Iwasaki, Hideki Sudo\uff1aAcellular, bioresorbable, ultra-purified alginate gel implantation for intervertebral disc herniation: Phase 1\/2, open-label, non-randomized clinical trials, Nature Communications, 16(1):4285, 10.1038\/s41467-025-59715-0.<\/td><\/tr>\n
39<\/th>Sakai K, Asada K, Watanabe Y<\/span>, Azuma H, Sakai H, Kasahara M, Matsumoto M\uff1aHaemoglobin vesicles as artificial red blood cells developed for use as a transfusion alternative: an open-label, single-centre phase Ib study protocol in Japan., BMJ open, 16:e110183, 10.1136\/ bmjopen-2025-110183<\/td><\/tr>\n
40<\/th>Osaki M, Terakura S, Hirano S, Iwasa T, Hatanaka KC<\/span>, Hatanaka Y<\/span>, Sunagawa M, Kokuryo T, Adachi Y, Takeuchi Y, Hanajiri R, Sakanaka C, Murata M, Ebata T, Kiyoi H\uff1aDevelopment and optimization of Eva1 (MPZL2) targeting chimeric antigen receptor T cells, J Immunother Cancer, 13(5):e009825, 10.1136\/jitc-2024-009825<\/td><\/tr>\n
41<\/th>Ito Y, Shimono J, Kawamoto K, Hatanaka KC<\/span>, Kogure Y, Tabata M, Saito Y, Mizuno K, Horie S, Mizukami Y, Koya J, Murakami K, Teshima T, Hatanaka Y<\/span>, Chiba K, Okada A, Shiraishi Y, Miyoshi H, Matsuno Y, Ohshima K, Kataoka K, Nakagawa M\uff1aTP53 and CDKN2A alterations define a poor prognostic subgroup in patients with nodal T follicular helper cell lymphoma, Leukemia, (7):1723-1734, 10.1038\/s41375-025-02631-5<\/td><\/tr>\n
42<\/th>Morinaga D, Sakakibara-Konishi J, Kamada R, Kashima M, Tsuji K, Ito S, Furuta M, Shoji T, Takashima Y, Kitai H, Ikezawa Y, Taguchi H, Kato T, Shinomiya Y, C Hatanaka K<\/span>, Hatanaka Y<\/span>, Konno S\uff1aFrequency and Prognostic Impact of Local Ablation Therapy for Oligoprogression in Non-Small Cell Lung Cancer, Thorac Cancer, (13):e70119, 10.1111\/1759-7714.70119<\/td><\/tr>\n
43<\/th>Ito S, Sakakibara-Konishi J, Sato M, Shoji T, Furuta M, Takahashi H, Tsuji K, Morinaga D, Kashima M, Kitai H, Kikuchi J, Kikuchi E, Hatanaka KC<\/span>, Hatanaka Y<\/span>, Hida K, Noguchi T, Konno S\uff1aMidkine Promotes Tumor Growth and Attenuates the Effect of Cisplatin in Small Cell Lung Cancer, Cancer Med, (13):e71034, 10.1002\/cam4.71034<\/td><\/tr>\n
44<\/th>Shigehara K, Kawai N, Shirosaki T, Ebihara Y, Murai A, Takaya A, Tokita S, Sasaki K, Shijubou N, Kubo T, Murata K, Kanaseki T, Tsukahara T, Hatanaka Y<\/span>, Mitsuhashi T, Shichinohe T, Hirohashi Y, Hirano S, Torigoe T\uff1aThe size of CD8+\u2009infiltrating T cells is a prognostic marker for esophageal squamous cell carcinoma, Sci Rep, 15(1):26638, 10.1038\/s41598-025-10885-3<\/td><\/tr>\n
45<\/th>Shinomiya Y, Ishida Y, Hatanaka KC<\/span>, Yamamoto M, Nange A, Okumura A<\/span>, Wada Y<\/span>, Abiko M, Shimizu T, Watanabe R, Hashimoto Y, Sato Y, Sakakibara-Konishi J, Kato T, Tanaka S, Hatanaka Y<\/span>\uff1aUtility of a Novel High-Sensitivity Multiplex Companion Diagnostic Test Using Formalin-Fixed Paraffin-Embedded Cell Block Materials of Non-small Cell Lung Cancer, Cancer Med, (13):e71028, 10.1002\/cam4.71028<\/td><\/tr>\n
46<\/th>Imai A, Tsunashima R, Hidaka Y, Kitano S, Kato C, Watanabe A, Morita M, Sakaguchi K, Sota Y, Suzuki M, Kinoshita T, Imanishi S, Oikawa M, Kamada Y, Ito KI, Oba T, Takayama S, Tsukamoto F, Takahashi M, Hatanaka Y<\/span>, Ueno NT, Shimazu K, Morita S, Naoi Y\uff1aValidation of the predictive ability for recurrence and the clinical utility of the 95-gene classifier (95GC) through an integrated analysis of five studies, Breast Cancer, 32(5):1075-1087, 10.1007\/s12282-025-01734-2<\/td><\/tr>\n
47<\/th>Nakamura T, Hatanaka KC<\/span>, Kawamoto Y, Kaneko S, Ishida K, Harada K, Yuki S, Komatsu Y, Hatanaka Y<\/span>, Sakamoto N\uff1aLack of association between SLFN11 expression and treatment efficacy or survival outcomes in patients with pancreatic ductal adenocarcinoma, J Cancer Res Clin Oncol, 151(5):159, 10.1007\/s00432-025-06216-8<\/td><\/tr>\n
48<\/th>Dai-Shinozaki A, Sakakibara-Konishi J, Hatanaka KC<\/span>, Wakabayashi K, Shinagawa N, Matsuno Y, Hatanaka Y<\/span>, Konno S\uff1aEffectiveness of afatinib after long-term gefitinib treatment for EGFR L858R and S768I compound mutation-positive lung adenocarcinoma: A case report, Respir Med Case Rep, 57:102249, 10.1016\/j.rmcr.2025.102249<\/td><\/tr>\n
49<\/th>Mitamura S, Ishikawa K, Hatanaka KC<\/span>, Saito T, Sasaki Y, Miura T, Maeda T, Funayama E, Murao N, Sasaki S, Hatanaka Y<\/span>\uff1aUltra-deep targeted next-generation sequencing with peripheral blood in patients with vascular malformations: a cohort of 40 patients, Mol Biol Rep, 53(1):214, 10.1007\/s11033-025-11371-9<\/td><\/tr>\n
50<\/th>Hatanaka KC<\/span>, Nishino K, Yokose T, Tanaka H, Motoi N, Taguchi K, Tamai Y, Hirai T, Yabuki Y, Hatanaka Y<\/span>\uff1aTumor Cell Proportion Assessment in Advanced Non-Squamous Non-Small Cell Lung Cancer Tissue Samples in Real-World Settings in Japan: The ASTRAL Study, Diagnostics (Basel), 15(17):2165, 10.3390\/diagnostics15172165<\/td><\/tr>\n
51<\/th>Sato Y, Kitai H, Takashima Y, Shinagawa N, Sakakibara-Konishi J, Ohkawa H, Hatanaka KC<\/span>, Hatanaka Y<\/span>, Yokouchi H, Konno S\uff1aSuccessful treatment of huntingtin-interacting protein-1-anaplastic lymphoma kinase-positive lung cancer with severe airway stenosis using silicone stent placement and alectinib, Respir Investig, 63(6):1365-1368, 10.1016\/j.resinv.2025.11.006<\/td><\/tr>\n
52<\/th>Nagamine M, Fujisawa T, Sakamoto N, Nakamura Y, Kadowaki S, Ueno M, Boku S, Komatsu Y, Oki E, Makiyama A, Nonomura N, Morizane C, Watari H, Okano S, Iwata H, Namikawa K, Hatanaka Y<\/span>, Hatanaka KC<\/span>, Taguchi K, Spetzler D, Radovich M, Magee D, Yoshino T, Oberley M, Kuwata T\uff1aHER2 Protein Overexpression, mRNA Expression, and DNA Amplification Across Solid Tumors: Comparison of Next-Generation Sequencing-Based Assays With Immunohistochemistry, JCO Precis Oncol, 10:e2500413, 10.1200\/PO-25-00413<\/td><\/tr>\n
53<\/th>Shimizu A, Hatanaka KC<\/span>, Nange A<\/span>, Okumura A<\/span>, Takehashi M, Shinomiya Y<\/span>, Naruchi K, Sato M, Kase H, Mitsuhashi T, Yamashita H, Hatanaka Y<\/span>, Matsuno Y\uff1aDiagnostic Potential of Tn-MUC1 in Breast Cancer: A Novel Immunohistochemical Marker Reflecting Tumor Progression, Lab Invest, 106(3):106070, 10.1016\/j.labinv.2025.106070<\/td><\/tr>\n
54<\/th>Shiratori S, Kawakubo K, Hatanaka KC<\/span>, Kobayashi T, Konishi T, Shinomiya Y<\/span>, Oda S, Nozawa S, Yonemura H, Sugiura R, Harada K, Nakanishi Y, Noji T, Tanaka S, Hirano S, Kuwatani M, Hatanaka Y<\/span>, Sakamoto N\uff1aHigh CD73 Expression Is Associated with Poor Prognosis in Biliary Tract Cancer Through Reduced Stromal Tumor-Infiltrating Lymphocytes, Cancers (Basel), 18(6):975, 10.3390\/cancers18060975<\/td><\/tr>\n
55<\/th>\u6a2a\u7530 \u5353<\/span>\uff1a\u9ad8\u8840\u5727\u306e\u57fa\u790e\u77e5\u8b58 , \u5317\u6d77\u9053\u5927\u5b66\u75c5\u9662\u306e\u304a\u3044\u3057\u3044\u5065\u5eb7\u3054\u306f\u3093 (\u5897\u88dc\u6539\u8a02\u7248), 18-19<\/td><\/tr>\n
56<\/th>\u6a2a\u7530 \u5353<\/span>\uff1a\u8102\u8cea\u7570\u5e38\u75c7\u306e\u57fa\u790e\u77e5\u8b58 , \u5317\u6d77\u9053\u5927\u5b66\u75c5\u9662\u306e\u304a\u3044\u3057\u3044\u5065\u5eb7\u3054\u306f\u3093 (\u5897\u88dc\u6539\u8a02\u7248), 54-55<\/td><\/tr>\n
57<\/th>\u7551\u4e2d \u8c4a<\/span>, \u56db\u5bae \u7fa9\u8cb4<\/span>, \u7551\u4e2d \u4f73\u5948\u5b50<\/span>\uff1a\u3010\u80ba\u764c\u306e\u8a3a\u65adI-\u85ac\u7269\u7642\u6cd5\u306e\u9032\u6b69\u3068\u5206\u5b50\u75c5\u7406\u8a3a\u65ad-\u3011\u80ba\u764c\u306b\u304a\u3051\u308bPD-L1\u514d\u75ab\u7d44\u7e54\u5316\u5b66\u691c\u67fb\u3000\u958b\u767a\u306e\u7d4c\u7def\u3068\u8a3a\u7642\u306e\u5b9f\u969b, \u75c5\u7406\u3068\u81e8\u5e8a, 44(1):39\u201346<\/td><\/tr>\n
58<\/th>\u7551\u4e2d \u8c4a<\/span>\uff1a\u4fdd\u967a\u8a3a\u7642\u3067\u7528\u3044\u3089\u308c\u308b\u514d\u75ab\u7d44\u7e54\u5316\u5b66\u691c\u67fb\u306e\u73fe\u72b6\u3068\u8ab2\u984c, \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u8a8c, 73(8): 647-649<\/td><\/tr>\n
59<\/th>\u7551\u4e2d \u4f73\u5948\u5b50<\/span>\uff1a\u7db2\u7f85\u7684\u907a\u4f1d\u5b50\u95a2\u9023\u691c\u67fb\u306e\u5b9f\u969b:\u5b9f\u52d9\u8005\u306e\u8996\u70b9\u304b\u3089\u3000\u304c\u3093\u907a\u4f1d\u5b50\u30d1\u30cd\u30eb\u691c\u67fb\u306e\u73fe\u72b6\u3068\u5c55\u671b\u3000\u75c5\u7406\u533b\u306e\u8996\u70b9\u304b\u3089, \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u8a8c, 73(6):453-456<\/td><\/tr>\n
60<\/th>\u7551\u4e2d \u4f73\u5948\u5b50<\/span>\uff1a\u907a\u4f1d\u5b50\u95a2\u9023\u691c\u67fb\u3092\u77e5\u308b\u3000\u304c\u3093\u30b2\u30ce\u30e0\u30d7\u30ed\u30d5\u30a1\u30a4\u30ea\u30f3\u30b0\u691c\u67fb\u63d0\u51fa\u6642\u306e\u691c\u4f53\u306e\u53d6\u308a\u6271\u3044\u3068\u691c\u51fa\u307e\u3067, \u907a\u4f1d\u5b50\u533b\u5b66, 15(1):111-115<\/td><\/tr>\n
61<\/th>\u56db\u5bae \u7fa9\u8cb4<\/span>\uff1a\u81e8\u5e8a\u691c\u67fbQ&A \u80ba\u764c\u306e\u304c\u3093\u907a\u4f1d\u5b50\u30d1\u30cd\u30eb\u691c\u67fb\u306b\u3064\u3044\u3066\u77e5\u308a\u305f\u3044\u3067\u3059, Medical Technology, 54(2)<\/td><\/tr>\n
62<\/th>\u4f50\u3005\u6728 \u7531\u7d00<\/span>\uff1a\u533b\u7642\u3068\u79c1\u305f\u3061\u306e\u672a\u6765\u4e88\u60f3\u56f3\u2161\uff5e\u77e5\u306e\u5275\u9020\u30fb\u5177\u73fe\u5316\u30fb\u5546\u696d\u5316 Wakka\u306e\u3054\u3068\u304f\uff5e, \u85ac\u7406\u3068\u6cbb\u7642\uff08JPT\uff09, vol.53 no,6:459-462<\/td><\/tr>\n
63<\/th>\u4e2d\u91ce\u91cd\u884c\u3001\u4f50\u3005\u6728 \u7531\u7d00<\/span>\uff1a\u300cCRC\u3042\u308a\u65b9\u4f1a\u8b70\u300d\u304c\u3064\u306a\u3050\u7d46\u2500\u76ee\u6307\u3057\u305f\u30b4\u30fc\u30eb\uff0c\u8a00\u970a\u306b\u8fbc\u3081\u305f\u60f3\u3044\u2500, \u85ac\u7406\u3068\u6cbb\u7642\uff08JPT\uff09, vol.53 no,7:581-589<\/td><\/tr>\n
64<\/th>Shimizu S, Osawa T, Sato M, Yamada S, Harabayashi T, Miki J, Kobayashi T, Hashine K, Kawashima A, Matsumoto T, Mochizuki T, Taoka R, Urabe F, Tatarano S, Sawada A, Kojima T, Takahashi A, Yokomizo A, Suekane S, Hashimoto K, Hashimoto Y, Yatsuda J, Morita K, Kobayashi K, Satake Y, Sazawa A, Matsui Y, Ito YM<\/span>, Nishiyama H, Kitamura H, Shinohara N, Fukuhara S; Japanese Urological Oncology Group\uff1aValidation of the 7-Item Quality of Life Disease-Specific Impact Scale in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Cross-Sectional Study., Int J Urol., 33(2):e70364, 10.1111\/iju.70364<\/td><\/tr>\n
65<\/th>Yamada S, Sato M, Osawa T, Harabayashi T, Miki J, Kobayashi T, Hashine K, Kawashima A, Matsumoto T, Mochizuki T, Taoka R, Urabe F, Tatarano S, Sawada A, Kojima T, Takahashi A, Yokomizo A, Suekane S, Hashimoto K, Hashimoto Y, Yatsuda J, Morita K, Kobayashi K, Satake Y, Sazawa A, Matsui Y, Ito YM<\/span>, Shimizu S, Fukuhara S, Nishiyama H, Kitamura H, Shinohara N; Japanese Urological Oncology Group\uff1aLongitudinal Impact of Urinary Diversion on Health-Related Quality of Life After Radical Cystectomy: A Multicenter Study in Japan., Cancer Sci., 117(3):739-748, 10.1111\/cas.70289<\/td><\/tr>\n
66<\/th>Shimizu K, Sugimori H, Tanabe N, Wakazono N, Ito YM<\/span>, Makita H, Sato S, Nishimura M, Hirai T, Konno S\uff1aSuperior performance of three-dimensional to two-dimensional convolutional neural network for predicting airflow limitation in patients with chronic obstructive pulmonary disease., Respir Investig., 63(6):1316-1325, 10.1016\/j.resinv.2025.10.008<\/td><\/tr>\n
67<\/th>Hattanda F, Sakuhara Y, Watanabe Y<\/span>, Nakazawa D, Ito YM<\/span>, Sato N<\/span>, Atsumi T, Nishio S\uff1aThe safety and effectiveness of transcatheter renal arterial embolization with tris-acryl gelatin microspheres in hemodialysis patients with autosomal dominant polycystic kidney disease., Clin Exp Nephrol., 30(1):126-134, 10.1007\/s10157-025-02759-9<\/td><\/tr>\n
68<\/th>Takahashi S, Nishioka K, Mori T, Yamaguchi S, Ishi Y, Kobashi K, Ito YM<\/span>, Tanei ZI, Kanno-Okada H, Tanaka S, Aoyama H\uff1aAssessment of prognostic value and development of predictive model for prolonged lymphopenia in patients with glioblastoma following chemoradiotherapy., J Radiat Res., 66(5):542-550, 10.1093\/jrr\/rraf045<\/td><\/tr>\n
69<\/th>Hattanda F, Watanabe Y<\/span>, Sakuhara Y, Takenaka S, Kawamura T, Matsuoka N, Nakazawa D, Ito YM<\/span>, Kondo H, Goto S, Isaka Y, Tsuchiya K, Mochizuki T, Muto S, Kawano H, Atsumi T, Nishio S\uff1aDevelopment and validation of a simplified CT volumetry for estimating total liver volume in patients with autosomal dominant polycystic kidney and liver disease., Clin Exp Nephrol., 29(12):1754-1763, 10.1007\/s10157-025-02721-9<\/td><\/tr>\n
70<\/th>Kano S, Kiyota N, Kinoshita I, Tada Y, Ijichi K, Yamazaki T, Shimizu Y, Hatanaka Y<\/span>, Tsuda H, Morinaga S, Matsuno Y, Ito YM<\/span>, Nishimoto N<\/span>, Kobayashi K, Isoe T, Noguchi T, Homma A, Dosaka-Akita H\uff1aMulticenter phase II trial of trastuzumab and docetaxel for HER2-positive salivary gland cancer., Jpn J Clin Oncol., 55(10):1131-1140, 10.1093\/jjco\/hyaf106<\/td><\/tr>\n
71<\/th>Fujii M, Nakamura T, Okumura Y, Ito YM<\/span>, Asano T, Hirano S\uff1aProjection of future demand for non-cancerous gastrointestinal surgery in Japan: challenges and workforce planning in an aging society., Surg Today., 55(9):1262-1268, 10.1007\/s00595-025-03027-9 <\/td><\/tr>\n
72<\/th>Kiriyama K, Kurashima Y, Poudel S, Watanabe Y<\/span>, Ito YM<\/span>, Hirano S\uff1aEnhancing surgical skills through telesimulation: A multicenter randomized controlled trial on laparoscopic inguinal hernia repair., Surgery., 83.2888888888889, 10.1016\/j.surg.2024.109136<\/td><\/tr>\n
73<\/th>Igarashi-Sugimoto A, Tsujino I, Shima H, Nakamura J, Nakaya T, Sato T, Watanabe T, Ohira H, Shimizu K, Yokota T<\/span>, Iwasaki S, Tsuneta S, Yokota I<\/span>, Konno S\uff1aReduced hemoglobin-corrected diffusing capacity in pulmonary arterial hypertension with preserved pulmonary function and morphology , Respir Investig, 63:600-607, 10.1016\/j.resinv.2025.04.002<\/td><\/tr>\n
74<\/th>Imaizumi T, Yokota T<\/span>, Funakoshi K, Yasuda K, Hattori A, Morohashi A, Kusakabe T<\/span>, Shojima M, Nagamine S, Nakano T, Huang Y, Morinaga H, Ohta M, Nagashima S, Inoue R, Nakamura N, Ota H, Maruyama T, Gobara H, Endoh A<\/span>, Ando M, Shiratori Y, Maruyama S\uff1aDevelopment and validation of an algorithm for identifying patients undergoing dialysis from patients with advanced chronic kidney disease, Clin Exp Nephrol, 29:650-661, 10.1007\/s10157-024-02614-3<\/td><\/tr>\n
75<\/th>\u52a0\u7551 \u99a8<\/span>\uff1aCAR-T\u7d30\u80de\u7642\u6cd5\u306e\u65bd\u8a2d\u8981\u4ef6\u306b\u3064\u3044\u3066\u6559\u3048\u3066\u4e0b\u3055\u3044\nCAR-T\u7d30\u80de\u7642\u6cd5\u306e\u6cbb\u7642\u8cbb\u306b\u3064\u3044\u3066\u6559\u3048\u3066\u4e0b\u3055\u3044, CAR-T\u7d30\u80de\u7642\u6cd5 Q\uff06A, <\/td><\/tr>\n
76<\/th>\u4f50\u4e45\u5d8b \u7814<\/span>\u3001\u5bae\u8170 \u5d07<\/span>\u3001\u6a2a\u5f0f \u6c99\u7d00<\/span>\uff1a\u30a2\u30ab\u30c7\u30df\u30a2\u306e\u7814\u7a76\u958b\u767a\u6210\u679c\u306e\u5b9f\u7528\u5316\u306e\u305f\u3081\u306e\u85ac\u4e8b\u30ac\u30a4\u30c9\u30d6\u30c3\u30af, ARO\u5354\u8b70\u4f1a\u85ac\u4e8b\u5c02\u9580\u5bb6\u9023\u7d61\u4f1a, <\/td><\/tr>\n
77<\/th>Bennett Levitan\uff0cKenneth Getz\uff0cEric L. Eisenstein\uff0c\u4ed6\uff08\u8a33\u3000\u89d2\u5185 \u7ae0\u4eba\uff0c\u6728\u4e0b \u96c4\u767b\uff0c\u5800\u6c5f \u5948\u7a42<\/span>\uff0c\u677e\u5c71 \u7434\u97f3\uff09\uff1a\u60a3\u8005\u53c2\u753b\uff08Patient Engagement\uff09\u306e\u7d4c\u6e08\u7684\u4fa1\u5024\u306e\u8a55\u4fa1\uff1aCTTI\u306e\u60a3\u8005\u30b0\u30eb\u30fc\u30d7\u3068\u81e8\u5e8a\u8a66\u9a13\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\u304b\u3089\u306e\u5b9a\u91cf\u7684\u30a2\u30d7\u30ed\u30fc\u30c1, \u81e8\u5e8a\u8a55\u4fa1, 473-88, 10.1177\/2168479017716715<\/td><\/tr>\n
78<\/th>\u7551\u4e2d \u4f73\u5948\u5b50<\/span>\uff1a\u4e2d\u67a2\u795e\u7d4c\u7cfb\u816b\u760d \u9650\u5c40\u6027\u661f\u7d30\u80de\u7cfb\u816b\u760d\uff0c\u5c0f\u5150\u816b\u760d \u816b\u760d\u75c5\u7406\u9451\u5225\u8a3a\u65ad\u30a2\u30c8\u30e9\u30b9\u3000\u7b2c1\u7248, \u533b\u5b66\u66f8\u9662, 74-83<\/td><\/tr>\n\n <\/tbody>\n\n <\/table>\n\n<\/div>\n\n

\u8868\u306f\u6a2a\u306b\u30b9\u30af\u30ed\u30fc\u30eb\u3057\u3066\u3054\u89a7\u3044\u305f\u3060\u3051\u307e\u3059<\/p>\n<\/div>\n\n\n\n

2. \u8b1b\u6f14<\/h3>\n\n\n\n
\n
\n\n \n\n \n\n \n\n <\/colgroup>\n\n \n\n
No<\/th>\n\n \u5b9f\u7e3e<\/th>\n\n <\/tr>\n\n <\/thead>\n\n
1<\/th>\u6a2a\u7530 \u5353<\/span>\uff1aUse of digital technology in heart failure management and cardiac rehabilitation in Japan , AsiaPRevent Expert Lecture, \u540d\u53e4\u5c4b\u5e02<\/td><\/tr>\n
2<\/th>Kankao Hatanaka<\/span>\uff1aMolecular Cytology, 4th Annual JHU-ASC-JSCC 2025 Joint Cytopathology Course, \u5e83\u5cf6\u770c<\/td><\/tr>\n
3<\/th>Yoshiki Shinomiya<\/span>\uff1aThe Evolving Role of Genetic Testing in Cancer Treatment: Current Status and Future Perspectives, The 74th Japanese Association of Medical Technologists (JAMT) Congress – International Symposium, \u5927\u962a\u5e9c\u5927\u962a\u5e02<\/td><\/tr>\n
4<\/th>\u5bfa\u7530 \u6d69\u83dc<\/span>\uff1a\u30fb\u81e8\u5e8a\u7814\u7a76\u6cd5\u306e\u6539\u6b63\u306b\u3064\u3044\u3066\u30fb\u7814\u7a76\u8a08\u753b\u304b\u3089CRB\u7533\u8acb\u307e\u3067\u306b\u884c\u3046\u4e8b\u9805\u30fbCRB\u7533\u8acb\u53ca\u3073\u95a2\u9023\u3059\u308b\u5831\u544a\u306b\u3064\u3044\u3066, \u4ee4\u548c7\u5e74\u672d\u5e4c\u533b\u79d1\u5927\u5b66\u9644\u5c5e\u75c5\u9662\u7279\u5b9a\u81e8\u5e8a\u7814\u7a76\u7814\u4fee\u4f1a, \u30aa\u30f3\u30e9\u30a4\u30f3<\/td><\/tr>\n
5<\/th>\u4e03\u6238 \u79c0\u592b<\/span>\uff1a\u300e\u30d8\u30eb\u30b7\u30f3\u30ad\u5ba3\u8a00\uff1a\u4eba\u9593\u306e\u53c2\u52a0\u8005\u3092\u542b\u3080\u533b\u5b66\u7814\u7a76\u306e\u305f\u3081\u306e\u502b\u7406\u7684\u539f\u5247\u300f\u306e2024\u5e74\u6539\u8a02\u306b\u3064\u3044\u3066, \u65e5\u672c\u8f38\u8840\u30fb\u7d30\u80de\u6cbb\u7642\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a, \u672d\u5e4c<\/td><\/tr>\n
6<\/th>\u4e03\u6238 \u79c0\u592b<\/span>\uff1a\u300e\u30d8\u30eb\u30b7\u30f3\u30ad\u5ba3\u8a00\uff1a\u4eba\u9593\u306e\u53c2\u52a0\u8005\u3092\u542b\u3080\u533b\u5b66\u7814\u7a76\u306e\u305f\u3081\u306e\u502b\u7406\u7684\u539f\u5247\u300f\u306e2024\u5e74\u6539\u8a02\u306b\u3064\u3044\u3066, \u5929\u4f7f\u5927\u5b66\u6559\u80b2\u8b1b\u6f14, \u30aa\u30f3\u30e9\u30a4\u30f3<\/td><\/tr>\n
7<\/th>\u9ad8\u6a4b \u9f8d\u6597<\/span>\uff1a\u54c1\u8cea\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u306b\u3064\u3044\u3066, \u5317\u5927RBA\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7, \u81e8\u5e8a\u7814\u7a76\u68df\u5927\u4f1a\u8b70\u5ba4<\/td><\/tr>\n
8<\/th>\u4f50\u4e45\u5d8b \u7814<\/span>\uff1a\u30db\u30c3\u30c8\u30c8\u30d4\u30c3\u30af\u30b903\u3000\u795e\u7d4c\u75be\u60a3\u306e\u30c9\u30e9\u30c3\u30b0\u30ed\u30b9\u554f\u984c\u3092\u8003\u3048\u308b \u7b4b\u840e\u7e2e\u6027\u5074\u7d22\u786c\u5316\u75c7\u306b\u304a\u3051\u308b\u30c9\u30e9\u30c3\u30b0\u30ed\u30b9\u306e\u73fe\u72b6\u3001\u89e3\u6c7a\u306b\u5411\u3051\u3066, \u7b2c66 \u56de\u2f47\u672c\u795e\u7d4c\u5b66\u4f1a\u5b66\u8853\u2f24\u4f1a, \u5927\u962a<\/td><\/tr>\n
9<\/th>\u4f50\u4e45\u5d8b \u7814<\/span>\uff1a\u7b4b\u840e\u7e2e\u6027\u5074\u7d22\u786c\u5316\u75c7\u306e\u958b\u767a\u4fc3\u9032\u306b\u5411\u3051\u3066\u795e\u7d4c\u6cbb\u7642\u5b66\u4f1a\u3068\u306e\u9023\u643a\u3082\u8e0f\u307e\u3048\u3066, \u7b2c22\u56de DIA\u65e5\u672c\u5e74\u4f1a2025, \u6771\u4eac<\/td><\/tr>\n
10<\/th>\u4f50\u4e45\u5d8b \u7814<\/span>\uff1a\u795e\u7d4c\u6cbb\u7642\u5b66\u4f1a\u306e\u56fd\u969b\u5316\u306e\u53d6\u308a\u7d44\u307f, \u7b2c43\u56de\u65e5\u672c\u795e\u7d4c\u6cbb\u7642\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, \u718a\u672c<\/td><\/tr>\n
11<\/th>\u4f50\u4e45\u5d8b \u7814<\/span>\uff1a\u7b4b\u840e\u7e2e\u6027\u5074\u7d22\u786c\u5316\u75c7\u306e\u6cbb\u7642\u85ac\u958b\u767a\u3068\u4eca\u5f8c\u306e\u5c55\u671b, \u7b2c46\u56de\u65e5\u672c\u81e8\u5e8a\u85ac\u7406\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a, \u6771\u4eac<\/td><\/tr>\n
12<\/th>\u6a2a\u7530 \u5353<\/span>\uff1a\u3053\u308c\u304b\u3089\u306e\u5fc3\u81d3\u30ea\u30cf\u30d3\u30ea\u30c6\u30fc\u30b7\u30e7\u30f3\u306b\u3064\u3044\u3066 , Collaborate Web Seminar\uff5e\u591a\u8077\u7a2e\u3067\u8a3a\u308b\u3053\u308c\u304b\u3089\u306e\u5730\u57df\u533b\u7642\uff5e, \u672d\u5e4c\u5e02\u304b\u3089WEB\u914d\u4fe1<\/td><\/tr>\n
13<\/th>\u6a2a\u7530 \u5353<\/span>\uff1a\u65b0\u3057\u3044\u30c7\u30d0\u30a4\u30b9 (IoT\u3001\u9060\u9694\u306a\u3069) \u3092\u7528\u3044\u305f\u5fc3\u81d3\u30ea\u30cf\u306e\u53d6\u308a\u7d44\u307f , \u7b2c44\u56de\u65e5\u672c\u81e8\u5e8a\u904b\u52d5\u7642\u6cd5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, \u6771\u4eac\u90fd<\/td><\/tr>\n
14<\/th>\u6a2a\u7530 \u5353<\/span>\uff1a\u30b2\u30ce\u30e0\u60c5\u5831\u3092\u6d3b\u7528\u3057\u305f\u6b21\u4e16\u4ee3\u578b\u5065\u8a3a \uff5e\u30dd\u30ea\u30b8\u30a7\u30cb\u30c3\u30af\u30ea\u30b9\u30af\u30b9\u30b3\u30a2(PRS)\u306b\u3088\u308b\u75be\u75c5\u767a\u75c7\u30ea\u30b9\u30af\u4e88\u6e2c\uff5e , \u4ee4\u548c7\u5e74\u5ea6 \u65e5\u81e8\u6280\u5317\u65e5\u672c\u652f\u90e8\u300c\u67d3\u8272\u4f53\u30fb\u907a\u4f1d\u5b50\u691c\u67fb\u90e8\u9580\u300d\u7814\u4fee\u4f1a, \u672d\u5e4c\u5e02\u304b\u3089WEB\u914d\u4fe1<\/td><\/tr>\n
15<\/th>\u6a2a\u7530 \u5353<\/span>\uff1a\u201c\u8a3a\u308b\u201d\u304b\u3089\u201d\u652f\u3048\u308b\u201d\u3078 \uff5e\u30c7\u30b8\u30bf\u30eb\u30d8\u30eb\u30b9\u30fbAI\u304c\u62d3\u304f\u6b21\u4e16\u4ee3\u533b\u7642\uff5e , \u793e\u4f1a\u4fdd\u967a\u652f\u6255\u57fa\u91d1\u5317\u6d77\u9053\u652f\u90e8\u8b1b\u6f14\u4f1a, \u672d\u5e4c\u5e02<\/td><\/tr>\n
16<\/th>\u6a2a\u7530 \u5353<\/span>\uff1a\u3048\u3063\u3001\u9ad8\u8840\u5727\u3082\uff1f\uff5e\u8a8d\u77e5\u75c7\u3068\u751f\u6d3b\u7fd2\u6163\u75c5\u306e\u3064\u306a\u304c\u308a\uff5e , \u7b2c4\u56de\u5036\u77e5\u5b89\u753a\u793e\u4f1a\u798f\u7949\u5927\u4f1a, \u5036\u77e5\u5b89\u753a<\/td><\/tr>\n
17<\/th>\u6a2a\u7530 \u5353<\/span>\uff1a\u9ad8\u8840\u5727\u3092\u9632\u3050\u65b0\u5e38\u8b58\uff5e\u304a\u3044\u3057\u304f\u98df\u3079\u3066\u5143\u6c17\u306b\u66ae\u3089\u3059\uff5e , \u30b7\u30cb\u30a2\u306e\u305f\u3081\u306e\u5065\u5eb7\u30bb\u30df\u30ca\u30fc, \u672d\u5e4c\u5e02<\/td><\/tr>\n
18<\/th>\u897f\u672c \u5c1a\u6a39<\/span>\uff1a\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u6982\u8ad6, \u539a\u751f\u52b4\u50cd\u7701\u81e8\u5e8a\u7814\u7a76\u7dcf\u5408\u4fc3\u9032\u4e8b\u696d 2025DM\u990a\u6210\u7814\u4fee, \u672d\u5e4c<\/td><\/tr>\n
19<\/th>\u52a0\u7551 \u99a8<\/span>\uff1a\u9662\u5185\u907a\u4f1d\u5b50\u30fb\u7d30\u80de\u6cbb\u7642\u88fd\u54c1\u306e\u53d6\u6271\u306e\u73fe\u5834\u304b\u3089, \u7b2c73\u56de\u8f38\u8840\u30fb\u7d30\u80de\u6cbb\u7642\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a, \u672d\u5e4c<\/td><\/tr>\n
20<\/th>\u52a0\u7551 \u99a8<\/span>\uff1a\u5317\u6d77\u9053\u5927\u5b66\u75c5\u9662 \u8840\u6db2\u5185\u79d1\u8a3a\u7642\u306e\u73fe\u72b6, \u30ce\u30db\u3099\u30ce\u30eb\u30c6\u3099\u30a3\u30b9\u30af\u30d5\u30a1\u30fc\u30de\u793e\u5185\u7814\u4fee\u4f1a, \u672d\u5e4c<\/td><\/tr>\n
21<\/th>\u52a0\u7551 \u99a8<\/span>\uff1a\u514d\u75ab\u6027\u8840\u5c0f\u677f\u6e1b\u5c11\u75c7\u306e\u75c5\u614b\u3068\u6cbb\u7642, \u30ad\u30c3\u30bb\u30a4\u85ac\u54c1\u793e\u5185\u52c9\u5f37\u4f1a, \u672d\u5e4c<\/td><\/tr>\n
22<\/th>\u52a0\u7551 \u99a8<\/span>\uff1a\u5317\u6d77\u9053\u306e\u8840\u53cb\u75c5\u8a3a\u7642\u9023\u643a\u301c\u3042\u3089\u305f\u306b\u30d6\u30ed\u30c3\u30af\u62e0\u70b9\u75c5\u9662\u3068\u306a\u3063\u305f\u5317\u5927\u75c5\u9662\u3067\u306e\u53d6\u308a\u7d44\u307f\u301c, \u5317\u6d77\u9053\u8840\u53cb\u75c5\u8a3a\u7642\u9023\u643a\u30bb\u30df\u30ca\u30fc, \u672d\u5e4c<\/td><\/tr>\n
23<\/th>\u52a0\u7551 \u99a8<\/span>\uff1a\u30a2\u30ab\u30c7\u30df\u30a2CPC\u306e\u4eba\u6750\u80b2\u6210\u306b\u304a\u3051\u308b\u8ab2\u984c, \u7b2c25\u56de\u65e5\u672c\u518d\u751f\u533b\u7642\u5b66\u4f1a\u7dcf\u4f1a, \u795e\u6238<\/td><\/tr>\n
24<\/th>\u52a0\u7551 \u99a8<\/span>\uff1a\u5973\u6027\u306e\u5148\u5929\u6027\u51fa\u8840\u6027\u75be\u60a3, \u6b6f\u79d1\u30fb\u7523\u5a66\u4eba\u79d1\u75be\u60a3\u5553\u767a\u30bb\u30df\u30ca\u30fc\uff08\u4e2d\u5916\uff09, \u672d\u5e4c<\/td><\/tr>\n
25<\/th>\u7551\u4e2d \u8c4a<\/span>\uff1a\u7d30\u80de\u691c\u4f53\u3092\u7528\u3044\u305f\u30b2\u30ce\u30e0\u8a3a\u7642\u306e\u4eca\u5f8c\u3068\u8ab2\u984c\u3000\u7d30\u80de\u691c\u4f53\u3092\u7528\u3044\u305f\u30b2\u30ce\u30e0\u8a3a\u7642\u306e\u4eca\u5f8c, \u7b2c66\u56de \u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u7dcf\u4f1a \u6625\u671f\u5927\u4f1a, \u6771\u4eac\u90fd<\/td><\/tr>\n
26<\/th>\u7551\u4e2d \u8c4a<\/span>\uff1a\u304c\u3093\u30b2\u30ce\u30e0\u533b\u7642\u306e\u5149\u3068\u5f71\u3000\u304c\u3093\u30b3\u30f3\u30d1\u30cb\u30aa\u30f3\u8a3a\u65ad\u306e\u73fe\u72b6\uff1a\u5149\u3068\u5f71, \u7b2c66\u56de \u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u7dcf\u4f1a \u6625\u671f\u5927\u4f1a, \u6771\u4eac\u90fd<\/td><\/tr>\n
27<\/th>\u7551\u4e2d \u8c4a<\/span>\uff1a\u304c\u3093\u30b2\u30ce\u30e0\u533b\u7642\u306b\u304a\u3051\u308b\u30b3\u30f3\u30d1\u30cb\u30aa\u30f3\u8a3a\u65ad\u306e\u8ab2\u984c\u3068\u5c55\u671b\u56fa\u5f62\u304c\u3093\u30b3\u30f3\u30d1\u30cb\u30aa\u30f3\u8a3a\u65ad\u306b\u304a\u3051\u308b\u73fe\u72b6\u3068\u8ab2\u984c, \u7b2c72\u56de \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a , \u5343\u8449\u770c<\/td><\/tr>\n
28<\/th>\u7551\u4e2d \u8c4a<\/span>\uff1a\u907a\u4f1d\u5b50\u30d1\u30cd\u30eb\uff08\u56fa\u5f62\u304c\u3093\uff65\u8840\u6db2\u304c\u3093\uff09\u691c\u67fb\u2f64\u75c5\u7406\u7d44\u7e54\u306e\u53d6\u308a\u6271\u3044, \u65e5\u672c\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a \u30b2\u30ce\u30e0\u533b\u7642\u6559\u80b2\u4e8b\u696d\u7b2c\uff14\u56de \u30b2\u30ce\u30e0\u533b\u7642\u3053\u3068\u306f\u3058\u3081 , WEB\u914d\u4fe1<\/td><\/tr>\n
29<\/th>\u7551\u4e2d \u8c4a<\/span>\uff1aPHC\u3067\u306e\u7814\u7a76\u30fb\u793e\u4f1a\u5b9f\u88c5\u306e\u53d6\u308a\u7d44\u307f, \u5065\u5eb7\u4fdd\u967a\u7d44\u5408\u7d4c\u55b6\u7814\u7a76\u4f1a \u5317\u5927\u75c5\u9662PHC\u898b\u5b66\u4f1a, \u672d\u5e4c<\/td><\/tr>\n
30<\/th>\u7551\u4e2d \u8c4a<\/span>\uff1aHER2\u306e\u4eca\u3068\u3053\u308c\u304b\u3089 \uff5e\u691c\u67fb\uff65\u8a3a\u65ad\u30fb\u7cbe\u5ea6\u7ba1\u7406\u305d\u3057\u3066\u6cbb\u7642\uff5e\u56fa\u5f62\u764cHER2\u691c\u67fbOverview, \u7b2c63\u56de \u65e5\u672c\u764c\u6cbb\u7642\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a \u30b9\u30dd\u30f3\u30b5\u30fc\u30c9\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff12, \u795e\u5948\u5ddd\u770c<\/td><\/tr>\n
31<\/th>\u7551\u4e2d \u8c4a<\/span>\uff1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e08\u3000\u75c5\u7406\u304c\u95a2\u308f\u308b\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u691c\u67fb\u30ac\u30a4\u30c0\u30f3\u30b9\u306e\u89e3\u8aac \u56fa\u5f62\u764c HER2\u75c5\u7406\u8a3a\u65ad\u30ac\u30a4\u30c0\u30f3\u30b9\u306e\u89e3\u8aac, \u7b2c64\u56de \u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u79cb\u671f\u5927\u4f1a, \u5e83\u5cf6\u770c<\/td><\/tr>\n
32<\/th>\u7551\u4e2d \u8c4a<\/span>\uff1a\u80ba\u764c\u30c9\u30e9\u30a4\u30d0\u30fc\u907a\u4f1d\u5b50\u5909\u7570\u691c\u51fa\u306b\u304a\u3051\u308b\u8ab2\u984c\u89e3\u6c7a\u306b\u5411\u3051\u3066\uff1a\u7b2c\u4e8c\u4e16\u4ee3\u30de\u30eb\u30c1\u30b3\u30f3\u30d1\u30cb\u30aa\u30f3\u8a3a\u65ad\u3078\u306e\u671f\u5f85, DNA\u30c1\u30c3\u30d7\u7814\u7a76\u6240\u4e3b\u50ac\u30aa\u30f3\u30e9\u30a4\u30f3\u30bb\u30df\u30ca\u30fc, WEB\u914d\u4fe1<\/td><\/tr>\n
33<\/th>\u7551\u4e2d \u8c4a<\/span>\uff1aPrecision Medicine\u3067\u63cf\u304f\u9577\u671f\u751f\u5b58\u6226\u7565\uff1a\u7532\u72b6\u817a\u764c\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u691c\u67fb\u306e\u73fe\u5728\u5730, Novartis Thyroid Cancer Web Seminar, WEB\u914d\u4fe1<\/td><\/tr>\n
34<\/th>\u7551\u4e2d \u8c4a<\/span>\uff1a\u80ba\u304c\u3093\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u306b\u6cbf\u3063\u305f\u907a\u4f1d\u5b50\u89e3\u6790\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8 \u80ba\u304c\u3093\u30b3\u30f3\u30d1\u30af\u30c8\u30d1\u30cd\u30eb\u306e\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u3068\u4eca\u5f8c\u306e\u5c55\u958b, DNA\u30c1\u30c3\u30d7\u7814\u7a76\u6240\u4e3b\u50ac\u30aa\u30f3\u30e9\u30a4\u30f3\u30bb\u30df\u30ca\u30fc, WEB\u914d\u4fe1<\/td><\/tr>\n
35<\/th>\u7551\u4e2d \u8c4a<\/span>\uff1a\u75c5\u7406\u304c\u95a2\u308f\u308b\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u691c\u67fb\u30ac\u30a4\u30c0\u30f3\u30b9\u306e\u89e3\u8aac\u3000\u56fa\u5f62\u764cHER2\u75c5\u7406\u8a3a\u65ad\u30ac\u30a4\u30c0\u30f3\u30b9(\u65e5\u672c\u75c5\u7406\u5b66\u4f1a)\u306e\u89e3\u8aac, \u7b2c64\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u79cb\u671f\u5927\u4f1a, \u5e83\u5cf6\u770c\u5e83\u5cf6\u5e02<\/td><\/tr>\n
36<\/th>\u7551\u4e2d \u8c4a<\/span>, \u56db\u5bae \u7fa9\u8cb4<\/span>, \u7551\u4e2d \u4f73\u5948\u5b50<\/span>\uff1a\u304c\u3093\u30b2\u30ce\u30e0\u533b\u7642\u306e\u5149\u3068\u5f71\u3000\u304c\u3093\u30b3\u30f3\u30d1\u30cb\u30aa\u30f3\u8a3a\u65ad\u306e\u73fe\u72b6\u3000\u5149\u3068\u5f71, \u7b2c66\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u6625\u671f\u5927\u4f1a, \u6771\u4eac\u90fd\u65b0\u5bbf\u533a<\/td><\/tr>\n
37<\/th>\u56db\u5bae \u7fa9\u8cb4<\/span>, \u7551\u4e2d \u4f73\u5948\u5b50<\/span>, \u5965\u6751 \u9ebb\u7f8e<\/span>, \u5357\u5bb6 \u7dbe\u6c5f<\/span>, \u7551\u4e2d \u8c4a<\/span>\uff1a\u7d30\u80de\u691c\u4f53\u3092\u7528\u3044\u305f\u30b2\u30ce\u30e0\u8a3a\u7642\u306e\u4eca\u5f8c\u3068\u8ab2\u984c\u3000\u7d30\u80de\u691c\u4f53\u3092\u7528\u3044\u305f\u5168\u30b2\u30ce\u30e0\u89e3\u6790\u306b\u95a2\u3059\u308b\u30d5\u30a3\u30fc\u30b8\u30d3\u30ea\u30c6\u30a3\u306e\u691c\u8a0e, \u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a, \u6771\u4eac\u90fd\u65b0\u5bbf\u533a<\/td><\/tr>\n
38<\/th>\u7551\u4e2d \u8c4a<\/span>, \u56db\u5bae \u7fa9\u8cb4<\/span>, \u7551\u4e2d \u4f73\u5948\u5b50<\/span>\uff1a\u7d30\u80de\u691c\u4f53\u3092\u7528\u3044\u305f\u30b2\u30ce\u30e0\u8a3a\u7642\u306e\u4eca\u5f8c\u3068\u8ab2\u984c\u3000\u7d30\u80de\u691c\u4f53\u3092\u7528\u3044\u305f\u30b2\u30ce\u30e0\u8a3a\u7642\u306e\u4eca\u5f8c, \u7b2c66\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u6625\u671f\u5927\u4f1a, \u6771\u4eac\u90fd\u65b0\u5bbf\u533a<\/td><\/tr>\n
39<\/th>\u7551\u4e2d \u8c4a<\/span>\uff1a\u304c\u3093\u30b2\u30ce\u30e0\u533b\u7642\u306b\u304a\u3051\u308b\u30b3\u30f3\u30d1\u30cb\u30aa\u30f3\u8a3a\u65ad\u306e\u8ab2\u984c\u3068\u5c55\u671b\u3000\u56fa\u5f62\u304c\u3093\u30b3\u30f3\u30d1\u30cb\u30aa\u30f3\u8a3a\u65ad\u306b\u304a\u3051\u308b\u73fe\u72b6\u3068\u8ab2\u984c, \u7b2c73\u56de\u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a , \u77f3\u5ddd\u770c\u91d1\u6ca2\u5e02<\/td><\/tr>\n
40<\/th>\u7551\u4e2d \u4f73\u5948\u5b50<\/span>\uff1a\u81e8\u5e8a\u8a66\u9a13\u306b\u4e00\u6b21\u767b\u9332\u3059\u308b\u3082\u8853\u4e2d\u8fc5\u901f\u8a3a\u65ad\u306b\u3066\u60aa\u6027\u795e\u7d4c\u81a0\u816b\u3068\u8a3a\u65ad\u3067\u304d\u305a\u767b\u9332\u306b\u81f3\u3089\u306a\u304b\u3063\u305f\u816b\u760d\u306e\u4e00\u4f8b\uff0c\u82e5\u5e74\u8005\u306e\u5f8c\u982d\u8449\u306b\u767a\u751f\u3057\u305f\uff0c\u816b\u760d\u6027\u75c5\u5909\u3068\u306e\u9451\u5225\u306b\u82e6\u616e\u3057\u305f\u8131\u9ac4\u6027\u75c5\u5909\u3093\u3068\u8003\u3048\u3089\u308c\u308b1\u4f8b, \u7b2c43\u56de\u65e5\u672c\u8133\u816b\u760d\u75c5\u7406\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, \u5c71\u5f62\u770c\u5c71\u5f62\u5e02<\/td><\/tr>\n
41<\/th>\u7551\u4e2d \u4f73\u5948\u5b50<\/span>\uff1aHOT AI-DP TR HOT2012:\u75c5\u7406\u306e\u7acb\u5834\u304b\u3089, \u7b2c55\u56de\u80ba\u764c\u81e8\u5e8a\u7814\u7a76\u4f1a, \u5317\u6d77\u9053\u672d\u5e4c\u5e02<\/td><\/tr>\n
42<\/th>\u7551\u4e2d \u4f73\u5948\u5b50<\/span>\uff1a\u304c\u3093\u30b2\u30ce\u30e0\u533b\u7642\u306b\u304a\u3051\u3046\u691c\u67fb\u306e\u7cbe\u5ea6\u78ba\u4fdd\u3068\u75c5\u7406\u306e\u5f79\u5272, \u7b2c72\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, \u5343\u8449\u770c\u5343\u8449\u5e02<\/td><\/tr>\n
43<\/th>\u56db\u5bae \u7fa9\u8cb4<\/span>\uff0c \u7551\u4e2d \u4f73\u5948\u5b50<\/span>\uff0c \u7551\u4e2d \u8c4a<\/span>\uff1a\u304c\u3093\u5168\u30b2\u30ce\u30e0\u89e3\u6790\u306b\u304a\u3051\u308b\u691c\u4f53\u53d6\u6271\u3044\u3068\u5b9f\u81e8\u5e8a\u691c\u4f53\u306eWGS\u5fdc\u7528, \u7b2c64\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u79cb\u671f\u5927\u4f1a, \u5e83\u5cf6\u770c\u5e83\u5cf6\u5e02<\/td><\/tr>\n
44<\/th>\u7551\u4e2d \u4f73\u5948\u5b50<\/span>\uff1a\u304c\u3093\u907a\u4f1d\u5b50\u30d1\u30cd\u30eb\u691c\u67fb\u306b\u304a\u3051\u308b\u691c\u4f53\u7ba1\u7406\u3068\u6210\u529f\u306e\u30b3\u30c4, \u304c\u3093\u30b2\u30ce\u30e0\u533b\u7642\u9023\u643a\u30d5\u30a9\u30fc\u30e9\u30e0, \u672d\u5e4c\u4f1a\u5834\u304b\u3089WEB\u914d\u4fe1<\/td><\/tr>\n
45<\/th>\u7551\u4e2d \u4f73\u5948\u5b50<\/span>\uff1a\u304c\u3093\u30b2\u30ce\u30e0\u30fbAI\u88dc\u52a9\u8a3a\u65ad\u6642\u4ee3\u306e\u75c5\u7406\u6a19\u672c\u4f5c\u88fd\u3068\u306f\u3000\u304c\u3093\u30b2\u30ce\u30e0\u533b\u7642\u6642\u4ee3\u306e\u75c5\u7406\u691c\u4f53, \u7b2c114\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a, \u5bae\u57ce\u770c\u4ed9\u53f0\u5e02<\/td><\/tr>\n
46<\/th>\u4f50\u3005\u6728 \u7531\u7d00<\/span>\uff1a\u518d\u751f\u533b\u7642\u7b49\u88fd\u54c1\u306e\u81e8\u5e8a\u8a66\u9a13\u3068CRC\u306e\u5f79\u5272, 2025\u5e74\u5ea6\u56fd\u516c\u79c1\u7acb\u5927\u5b66\u75c5\u9662\u533b\u7642\u6280\u8853\u95a2\u4fc2\u8077\u54e1\u7814\u4fee, WEB<\/td><\/tr>\n
47<\/th>\u4f50\u3005\u6728 \u7531\u7d00<\/span>\uff1a\u696d\u52d9\u52b9\u7387\u5316\u306b\u5411\u3051\u305fICH E6\uff08R3\uff09\u53ca\u3073E8\uff08R1\uff09\u306e\u5b9f\u88c5\uff1a\u6cbb\u9a13\u4f9d\u983c\u8005\u3068\u533b\u7642\u6a5f\u95a2\u304c\u30a2\u30b8\u30e3\u30a4\u30eb\u306b\u8ab2\u984c\u3092\u89e3\u6c7a\u3059\u308b\u65b9\u6cd5\u691c\u8a0e\u3001\u73fe\u5834\u30ec\u30d9\u30eb\u306e\u8ab2\u984c\u3068\u3057\u3066\u5317\u6d77\u9053\u5927\u5b66\u75c5\u9662\u306e\u4e8b\u4f8b, \u7b2c22\u56de DIA\u65e5\u672c\u5e74\u4f1a2025, \u6771\u4eac<\/td><\/tr>\n
48<\/th>\u4f50\u3005\u6728 \u7531\u7d00<\/span>\uff1a\u81e8\u5e8a\u7814\u7a76\uff08\u96c6\u5b66\u7684\uff09\u30c1\u30fc\u30e0\u306b\u304a\u3051\u308b\u9069\u5207\u306a\u30b3\u30df\u30e5\u30cb\u30b1\u30fc\u30b7\u30e7\u30f3\u81e8\u5e8a\u7814\u7a76\u306e\u95a2\u4fc2\u8005\u3068\u306e\u5408\u610f\u5f62\u6210\u30d7\u30ed\u30bb\u30b9\u3068\u624b\u6cd5, \u4e0a\u7d1a\u8005\u81e8\u5e8a\u7814\u7a76\u30b3\u30fc\u30c7\u30a3\u30cd\u30fc\u30bf\u30fc\u990a\u6210\u7814\u4fee(e\u30e9\u30fc\u30cb\u30f3\u30b0\uff09, WEB<\/td><\/tr>\n
49<\/th>\u4f50\u3005\u6728 \u7531\u7d00<\/span>\uff1a\u30aa\u30e9\u30f3\u30c0\u3067\u306eCRC\u6d77\u5916\u7814\u4fee\u3092\u632f\u308a\u8fd4\u3063\u3066, \u7b2c46 \u56de\u65e5\u672c\u81e8\u5e8a\u85ac\u7406\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff08\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff09, \u6771\u4eac<\/td><\/tr>\n
50<\/th>\u4f50\u85e4 \u5178\u5b8f<\/span>\uff1a\u6539\u6b63\u81e8\u5e8a\u7814\u7a76\u6cd5 \u7814\u7a76\u5bfe\u8c61\u8005\u306b\u8457\u3057\u3044\u8ca0\u62c5\u3092\u4e0e\u3048\u308b\u691c\u67fb\u7b49\u306e\u8003\u3048\u65b9, \u56fd\u7acb\u304c\u3093\u7814\u7a76\u30bb\u30f3\u30bf\u30fc\u6771\u75c5\u9662\u3000\u81e8\u5e8a\u7814\u7a76\u30bb\u30df\u30ca\u30fc, WEB<\/td><\/tr>\n
51<\/th>\u4f50\u85e4 \u5178\u5b8f<\/span>\uff1a\u81e8\u5e8a\u7814\u7a76\u6cd5\u6539\u6b63 \u8457\u3057\u3044\u8ca0\u62c5\u3092\u4e0e\u3048\u308b\u691c\u67fb\u7b49\u306e\u9069\u7528\u7bc4\u56f2\u3068\u8003\u3048\u65b9, \u7b2c71\u56de\u533b\u5b66\u7cfb\u5927\u5b66\u502b\u7406\u59d4\u54e1\u4f1a\u9023\u7d61\u4f1a\u8b70 \u5b66\u8853\u96c6\u4f1a, \u6a2a\u6d5c<\/td><\/tr>\n
52<\/th>\u4f50\u85e4 \u5178\u5b8f<\/span>\uff1a\u81e8\u5e8a\u7814\u7a76\u6cd5\u6539\u6b63\u5f8c\u306e\u73fe\u72b6, \u56fd\u7acb\u75c5\u9662\u6a5f\u69cb\u306e\u81e8\u5e8a\u7814\u7a76\u30bb\u30f3\u30bf\u30fc\u9577\u30fb\u81e8\u5e8a\u7814\u7a76\u90e8\u9577\u5354\u8b70\u4f1a, \u91d1\u6ca2<\/td><\/tr>\n
53<\/th>\u6a2a\u7530 \u5353<\/span>, \u4e0a\u7530 \u826f\u592a, \u4f50\u4f2f\u3000\u8f1d\u660e\uff1a\u907a\u4f1d\u5b50\u00d7\u30d5\u30a3\u30c3\u30c8\u30cd\u30b9? \u691c\u67fb\u7d50\u679c\u304b\u3089\u8aad\u307f\u89e3\u304f\u4f53\u8cea\u5225\u306e\u904b\u52d5\u4e8b\u4f8b\u3068\u305d\u306e\u5834\u3067\u3067\u304d\u308b\u7c21\u5358\u30a8\u30af\u30b5\u30b5\u30a4\u30ba , \u5317\u6d77\u9053\u5927\u5b66 \u30b5\u30a4\u30a8\u30f3\u30b9\u30d5\u30a7\u30b9\u30bf2025, \u672d\u5e4c\u5e02<\/td><\/tr>\n
54<\/th>\u524d\u7530 \u4e00\u90ce, \u661f\u91ce \u662d\u82b3, \u5927\u4e95 \u606d\u4ee3, \u6d25\u7530 \u5747, \u5c71\u53e3 \u502b, \u9ed2\u7530 \u4e00, \u6749\u6c5f \u77e5\u6cbb, \u7551\u4e2d \u8c4a<\/span>\uff1a\u4e73\u764c\u53d6\u6271\u3044\u898f\u7d04\u7b2c19\u7248\u306e\u6539\u8a02\u70b9\u3068\u305d\u306e\u8981\u70b9\u3000\u8089\u773c\u578b\u5206\u985e(\u8089\u773c\/\u30eb\u30fc\u30da\u50cf\u5206\u985e)\u30fb\u4e73\u764c\u306e\u907a\u4f1d\u5b50, \u7b2c64\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u79cb\u671f\u5927\u4f1a, \u5e83\u5cf6\u770c\u5e83\u5cf6\u5e02<\/td><\/tr>\n
55<\/th>\u7551\u4e2d \u4f73\u5948\u5b50<\/span>, \u56db\u5bae \u7fa9\u8cb4<\/span>, \u5965\u6751 \u9ebb\u7f8e<\/span>, \u68ee\u4e95 \u82f1\u4e00, \u4f50\u85e4 \u4e4b\u4fca, \u7551\u4e2d \u8c4a<\/span>\uff1a\u304c\u3093\u30b2\u30ce\u30e0\u8a3a\u7642\u306b\u304a\u3051\u308b\u7d30\u80de\u691c\u4f53\u306e\u53d6\u6271\u3044\u6307\u91dd, \u7b2c66\u56de\u80ba\u764c\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a<\/td><\/tr>\n
56<\/th>\u7551\u4e2d \u8c4a<\/span>, \u56db\u5bae \u7fa9\u8cb4<\/span>, \u6a2a\u5185 \u6d69, \u4f50\u3005\u6728 \u9ad8\u660e, \u698a\u539f \u7d14, \u54c1\u5ddd \u5c1a\u6587, \u7551\u4e2d \u4f73\u5948\u5b50<\/span>, \u5927\u6cc9 \u8061\u53f2\uff1a\u6c17\u7ba1\u652f\u93e1\u306b\u3088\u308b\u691c\u4f53\u63a1\u53d6\u3068\u6cbb\u7642\u306e\u6700\u524d\u7dda\u3000\u30de\u30eb\u30c1\u907a\u4f1d\u5b50\u691c\u67fb\u306b\u6700\u9069\u306a\u691c\u4f53\u3068\u306f, \u7b2c66\u56de\u80ba\u764c\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a<\/td><\/tr>\n
57<\/th>\u5bcc\u5ca1 \u4f38\u5143, \u7551\u4e2d \u4f73\u5948\u5b50<\/span>, \u5c0f\u6797 \u62d3\u99ac, \u5965\u5c71 \u5927, \u5c0f\u91d1\u6fa4 \u5343\u590f, \u6577\u5cf6 \u679c\u6797, \u592a\u5200\u5ddd \u82b1\u6075, \u5c71\u672c \u8ca2, \u6e21\u908a \u5065\u4e00, \u5927\u4e45\u4fdd \u4e9c\u5e0c\u5b50, \u6771 \u5b66, \u6e05\u6c34 \u4e9c\u8863, \u5c0f\u897f \u54f2\u5e73, \u7551\u4e2d \u8c4a\uff1a\u4e73\u764c\u9818\u57df\u306b\u304a\u3051\u308b\u514d\u75ab\u7642\u6cd5\u306e\u9032\u6b69(ICI\u3001ICI+ADC\u3001TIL\u7642\u6cd5\u3001RNA\u30ef\u30af\u30c1\u30f3+ICI)\u3000\u30c8\u30ea\u30d7\u30eb\u30cd\u30ac\u30c6\u30a3\u30d6\u4e73\u764c(TNBC)\u306b\u304a\u3051\u308bTILs\u3084PD-L1\u306eAI\u89e3\u6790\u306e\u6709\u7528\u6027, \u7b2c33\u56de\u65e5\u672c\u4e73\u764c\u5b66\u4f1a\u7dcf\u4f1a, \u6771\u4eac\u90fd\u65b0\u5bbf\u533a<\/td><\/tr>\n
58<\/th>\u7551\u4e2d \u4f73\u5948\u5b50<\/span>\uff0c\u56db\u5bae \u7fa9\u8cb4<\/span>\uff0c\u5965\u6751 \u9ebb\u7f8e<\/span>\uff0c\u68ee\u4e95 \u82f1\u4e00\uff0c\u4f50\u85e4 \u4e4b\u4fca\uff0c\u7551\u4e2d \u8c4a<\/span>\uff1a\u304c\u3093\u30b2\u30ce\u30e0\u8a3a\u7642\u306b\u304a\u3051\u308b\u7d30\u80de\u691c\u4f53\u306e\u53d6\u308a\u6271\u3044\u6307\u91dd, \u7b2c66\u56de\u65e5\u672c\u80ba\u764c\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a<\/td><\/tr>\n <\/tbody>\n <\/table>\n<\/div>\n

\u8868\u306f\u6a2a\u306b\u30b9\u30af\u30ed\u30fc\u30eb\u3057\u3066\u3054\u89a7\u3044\u305f\u3060\u3051\u307e\u3059<\/p>\n<\/div>\n\n\n\n

3. \u4e00\u822c\u6f14\u984c\uff08\u53e3\u6f14\uff09<\/h3>\n\n\n\n
\n
\n\n \n\n \n\n \n\n <\/colgroup>\n\n \n\n
No<\/th>\n\n \u5b9f\u7e3e<\/th>\n\n <\/tr>\n\n <\/thead>\n\n
1<\/th>\u6a2a\u7530 \u52f2<\/span>\uff1a3\u6a5f\u7a2e\u4ee5\u4e0a\u306e\u81e8\u5e8a\u691c\u67fb\u5024\u76f8\u4e92\u63db\u7b97\u5f0f\u306e\u30ce\u30f3\u30d1\u30e9\u30e1\u30c8\u30ea\u30c3\u30af\u63a8\u5b9a\u6cd5\uff1a\u8ef8(\u8d85)\u7403\u9762\u4e2d\u592e\u5024\u63a8\u5b9a\u6cd5 , 2025\u5e74\u5ea6\u65e5\u672c\u8a08\u91cf\u751f\u7269\u5b66\u4f1a\u5e74\u4f1a, \u5bcc\u5c71\u5e02<\/td><\/tr>\n
2<\/th>\u897f\u672c \u5c1a\u6a39<\/span>\uff0c\u5409\u6c38 \u548c\u7f8e<\/span>\uff0c\u88b4\u7530 \u9065<\/span>\uff0c\u5317\u5c71 \u9999\u7e54\u7406<\/span>\uff0c\u963f\u90e8 \u6dbc<\/span>\uff1a\u81e8\u5e8a\u8a66\u9a13\u30c7\u30fc\u30bf\u30bb\u30f3\u30bf\u30fc\u306e\u8077\u5834\u5185\u7121\u4f5c\u6cd5\u306e\u81ea\u7136\u7d4c\u904e\u306b\u5bfe\u3059\u308b\u30b7\u30df\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3. , \u7b2c53\u56de\u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a\u79cb\u5b63\u5b66\u8853\u5927\u4f1a\uff08\u672d\u5e4c\uff09, \u672d\u5e4c<\/td><\/tr>\n
3<\/th>\u5bae\u8170 \u5d07<\/span>\uff1a\u516c\u7684\u30a6\u30a7\u30a2\u30e9\u30d6\u30eb\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u3092\u7528\u3044\u305f\u8840\u7cd6\u30c7\u30fc\u30bf\u3001\u2f63\u7406\u5b66\u7684\u30c7\u30fc\u30bf\u53ca\u3073\u2fb7\u4e8b\u8abf\u67fb\u304b\u3089\u306e\u6804\u990a\u5b66\u7684\u30c7\u30fc\u30bf\u306e\u95a2\u9023\u306e\u691c\u8a0e, \u9023\u643a\u7814\u7a76\u30bb\u30f3\u30bf\u30fc\u7814\u7a76\u6210\u679c\u767a\u8868\u4f1a, \u672d\u5e4c<\/td><\/tr>\n
4<\/th>\u6a4b\u672c \u3042\u304d\u3089<\/span>\uff1a\u5317\u6d77\u9053\u5927\u5b66\u75c5\u9662\u306e\u6cbb\u9a13\u52b9\u7387\u5316\u306e\u53d6\u308a\u7d44\u307f\u3000\u6cbb\u9a13\u30a8\u30b3\u30b7\u30b9\u30c6\u30e0\u306e\u6e96\u5099\u72b6\u6cc1\u3068\u8ab2\u984c, \u7b2c9\u56deTG2\u5317\u6d77\u9053\u30fb\u6771\u5317\u5730\u533a\u5171\u540c\u8b1b\u6f14\u4f1a, \u4ed9\u53f0<\/td><\/tr>\n
5<\/th>\u5e84\u5b50 \u96c5\u4fca<\/span>\u3001\u7530\u4e2d \u53f8\u6717\u3001\u6a2a\u7530 \u52f2<\/span>\uff1a\u30b7\u30df\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\u306b\u3088\u308b\u30ec\u30a2\u30a4\u30d9\u30f3\u30c8\u306e\u4eee\u5b9a\u304c\u5d29\u308c\u305f\u5834\u5408\u306e\u672a\u6e2c\u5b9a\u4ea4\u7d61\u306b\u5bfe\u3059\u308bCox\u56de\u5e30\u3067\u306e\u611f\u5ea6\u89e3\u6790\u6cd5, 2025\u5e74\u5ea6 \u7d71\u8a08\u95a2\u9023\u9023\u5408\u5927\u4f1a, \u5927\u962a<\/td><\/tr>\n
6<\/th>\u897f\u672c \u5c1a\u6a39<\/span>\u3001\u8c37\u5ddd\u539f \u7dbe\u5b50. \u97d3 \u8c4a\u3001\u5e73\u7530 \u5065\u53f8\uff1a\u5927\u898f\u6a21\u8a00\u8a9e\u30e2\u30c7\u30eb\u306b\u3088\u308b\u6838\u533b\u5b66\u30ec\u30dd\u30fc\u30c8\u3092\u5bfe\u8c61\u3068\u3057\u305fCDISC\u9805\u76ee\u306e\u62bd\u51fa\u3068\u7cbe\u5ea6\u8a55\u4fa1, \u65e5\u672c\u533b\u7642\u60c5\u5831\u5b66\u4f1a\u7b2c25\u56de\u5317\u6d77\u9053\u652f\u90e8\u4f1a\u5b66\u8853\u5927\u4f1a, \u672d\u5e4c<\/td><\/tr>\n
7<\/th>\u897f\u672c \u5c1a\u6a39<\/span>\u3001\u8c37\u5ddd\u539f \u7dbe\u5b50\uff1aMEDINFO2025\u30ec\u30d3\u30e5\u30fc-\u533b\u7642\u60c5\u5831\u5b66\u4f1a\u306e\u56fd\u969b\u5927\u4f1a\u3067\u306e\u30c8\u30d4\u30c3\u30af\u306b\u3064\u3044\u3066-, \u65e5\u672c\u533b\u7642\u60c5\u5831\u5b66\u4f1a\u7b2c25\u56de\u5317\u6d77\u9053\u652f\u90e8\u4f1a\u5b66\u8853\u5927\u4f1a, \u672d\u5e4c<\/td><\/tr>\n
8<\/th>\u5800\u6c5f \u5948\u7a42<\/span>\uff1aARO\u306b\u304a\u3051\u308b Agatha\u3068\u6b69\u3080\u6cbb\u9a13\u6587\u66f8\u7ba1\u7406, Agatha Connect 2025, \u6771\u4eac<\/td><\/tr>\n
9<\/th>\u5800\u6c5f \u5948\u7a42<\/span>\uff1a\u5e02\u6c11\u516c\u958b\u8b1b\u5ea7\uff1a\u5317\u6d77\u9053\u5927\u5b66\u75c5\u9662\u306ePPI\u6d3b\u52d5\u4e8b\u4f8b\uff1a\u5927\u5b66\u796d\u306b\u304a\u3051\u308b\u6a4b\u6e21\u3057\u30b7\u30fc\u30ba\u7d39\u4ecb, ARO\u5354\u8b70\u4f1a\u7b2c12\u56de\u5b66\u8853\u96c6\u4f1a, \u5343\u8449<\/td><\/tr>\n
10<\/th>\u5800\u6c5f \u5948\u7a42<\/span>, \u9577\u5c3e \u5178\u660e, \u4f50\u85e4 \u9686, \u4eca\u4e95 \u7a63, \u6751\u6a4b \u7531\u9999\u83dc, \u9234\u6728 \u5553\u53f2, \u5c0f\u6751 \u60a0, \u5ca1\u5d0e \u611b\uff1a\u30d7\u30ed\u30b0\u30e9\u30e0\u30fb\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u306b\u3088\u308b\u4fa1\u5024\u5275\u9020-\u300c\u60a3\u8005\u3055\u3093\u306e\u660e\u65e5\u306e\u3042\u305f\u308a\u307e\u3048\u300d\u306e\u305f\u3081\u306b-, DIA Japam2025, \u6771\u4eac<\/td><\/tr>\n
11<\/th>\u7be0\u5d0e \u9b8e\u9999, \u698a\u539f \u7d14, \u4e09\u7530 \u660e\u97f3, \u53e4\u7530 \u6075, \u5317\u4e95 \u79c0\u5178, \u4eca\u91ce \u54f2, \u82e5\u6797 \u5065\u4eba, \u7551\u4e2d \u4f73\u5948\u5b50<\/span>, \u7551\u4e2d \u8c4a<\/span>, \u6e9d\u6e15 \u6709\u7f8e, \u6728\u6751 \u592a\u4fca, \u9ad8\u6a4b \u5b8f\u5178, \u54c1\u5ddd \u5c1a\u6587, \u677e\u91ce \u5409\u5b8f\uff1a\u30b2\u30d5\u30a3\u30c1\u30cb\u30d6\u9577\u671f\u6cbb\u7642\u5f8c\u306b\u30a2\u30d5\u30a1\u30c1\u30cb\u30d6\u304c\u594f\u52b9\u3057\u305fEGFR L858R\/S768I\u5909\u7570\u967d\u6027\u80ba\u817a\u764c\u306e1\u4f8b, \u7b2c52\u56de\u65e5\u672c\u80ba\u764c\u5b66\u4f1a\u5317\u6d77\u9053\u652f\u90e8\u5b66\u8853\u96c6\u4f1a, \u672d\u5e4c\u5e02<\/td><\/tr>\n
12<\/th>\u6d5c\u7530 \u5353\u5df3, \u4eca\u6cc9 \u5065, \u7551\u4e2d \u4f73\u5948\u5b50<\/span>, \u7551\u4e2d \u8c4a<\/span>, \u77f3\u9ed2 \u53cb\u552f, \u4e0b\u570b \u9054\u5fd7, \u677e\u4e95 \u535a\u7d00, \u5409\u7530 \u96c5, \u5e02\u5ddd \u4f38\u6a39, \u6b66\u51a8 \u7d39\u4fe1\uff1a\u9589\u585e\u6027\u5927\u8178\u764c\u306e\u91d1\u5c5e\u30b9\u30c6\u30f3\u30c8\u7559\u7f6e\u306b\u3088\u308b\u75c5\u7406\u7d44\u7e54\u5b66\u6240\u898b\u306b\u4e0e\u3048\u308b\u5f71\u97ff\u306e\u89e3\u660e, \u7b2c80\u56de\u65e5\u672c\u6d88\u5316\u5668\u5916\u79d1\u5b66\u4f1a\u7dcf\u4f1a , \u5175\u5eab\u770c\u795e\u6238\u5e02<\/td><\/tr>\n
13<\/th>\u59dc \u535a\u6587, \u677e\u5ca1 \u6b63\u525b, \u7551\u4e2d \u4f73\u5948\u5b50<\/span>, \u4e2d\u91cc \u4fe1\u4e00, \u4e2d\u6751 \u30cf\u30eb\u30df, \u4e2d\u6751 \u8aa0\u4e8c, \u5c0f\u91ce\u5bfa \u667a\u6d0b, \u7530\u4e2d \u4f38\u54c9, \u7551\u4e2d \u8c4a<\/span>, \u5ca9\u5d0e \u502b\u653f\uff1a\u7b4b\u4e0a\u76ae\u7cfb\u30de\u30fc\u30ab\u30fc\u304c\u967d\u6027\u3068\u306a\u3063\u305fextraskeletal myxoid chondrosarcom\u306e1\u4f8b, \u7b2c58\u56de \u65e5\u672c\u6574\u5f62\u5916\u79d1\u5b66\u4f1a\u9aa8\u30fb\u8edf\u90e8\u816b\u760d\u5b66\u8853\u96c6\u4f1a, \u5948\u826f\u770c\u5948\u826f\u5e02<\/td><\/tr>\n
14<\/th>\u9ad8\u6728 \u7d71\u4e00\u90ce, \u6cb3\u4e95 \u5eb7\u5b5d, \u7f85 \u660a, \u6728\u6751 \u592a\u4fca, \u5c0f\u718a \u6602, \u7267\u7530 \u5553\u53f2, \u56db\u5bae \u7fa9\u8cb4<\/span>, \u7551\u4e2d \u4f73\u5948\u5b50<\/span>, \u7551\u4e2d \u8c4a<\/span>, \u6c60\u6fa4 \u9756\u5143\uff1a4\u7a2e\u985e\u306e\u7d44\u7e54\u578b\u3092\u542b\u3093\u3060\u6df7\u5408\u578b\u5c0f\u7d30\u80de\u80ba\u764c\u306e1\u5207\u9664\u4f8b, \u7b2c2\u56de\u547c\u5438\u5668\u95a2\u9023 5 \u5b66\u4f1a\u5408\u540c\u5317\u6d77\u9053\u5730\u65b9\u4f1a, \u5317\u6d77\u9053\u672d\u5e4c\u5e02<\/td><\/tr>\n
15<\/th>\u6e05\u7530 \u5c1a\u81e3, \u6728\u4e0b \u4e00\u90ce, \u52a0\u7d0d \u91cc\u5fd7, \u672c\u9593 \u7fa9\u5d07, \u7530\u539f \u4fe1, \u798f\u7530 \u76f4\u6a39, \u4f0a\u85e4 \u967d\u4e00, \u7551\u4e2d \u8c4a<\/span>, \u677e\u91ce \u5409\u5b8f, \u79cb\u7530 \u5f18\u4fca\uff1aHER2\u967d\u6027\u553e\u6db2\u817a\u304c\u3093\u306b\u5bfe\u3059\u308b\u30c8\u30e9\u30b9\u30c4\u30de\u30d6\u30fb\u30c7\u30eb\u30af\u30b9\u30c6\u30ab\u30f3\u306e\u7b2c2\u76f8\u8a66\u9a13, \u7b2c49\u56de\u65e5\u672c\u982d\u9838\u90e8\u764c\u5b66\u4f1a, \u5317\u6d77\u9053\u672d\u5e4c\u5e02<\/td><\/tr>\n
16<\/th>\u4f50\u85e4 \u7950\u9ebb, \u5317\u4e95 \u79c0\u5178, \u7530\u4e0a \u656c\u592a, \u77f3\u7530 \u6709\u8389\u5b50, \u7be0\u5d0e \u9b8e\u9999, \u4f50\u85e4 \u5cf0\u5609, \u9ad8\u6a4b \u5b8f\u5178, \u53e4\u7530 \u6075, \u9ad8\u5cf6 \u96c4\u592a, \u5e84\u53f8 \u54f2\u660e, \u6c60\u6fa4 \u9756\u5143, \u698a\u539f \u7d14, \u54c1\u5ddd \u5c1a\u6587, \u4eca\u91ce \u54f2, \u5927\u5ddd \u7d18\u5f25, \u5927\u585a \u7d00\u5e78, \u7551\u4e2d \u4f73\u5948\u5b50<\/span>, \u7551\u4e2d \u8c4a<\/span>, \u6a2a\u5185 \u6d69\uff1a\u6c17\u7ba1\u652f\u72ed\u7a84\u62e1\u5f35\u8853\u5f8c\u306bALK-TKI\u3092\u5c0e\u5165\u3057\u305fHIP1-ALK\u967d\u6027\u80ba\u764c\u306e1\u4f8b, \u7b2c1\u56de\u547c\u5438\u5668\u95a2\u9023 5 \u5b66\u4f1a\u5408\u540c\u5317\u6d77\u9053\u5730\u65b9\u4f1a, \u5317\u6d77\u9053\u672d\u5e4c\u5e02<\/td><\/tr>\n
17<\/th>\u4f50\u85e4 \u5f69, \u6298\u8302 \u9054\u4e5f, \u7551\u4e2d \u4f73\u5948\u5b50<\/span>, \u8107\u5742 \u548c\u8cb4, \u76f8\u5c71 \u5065, \u67ff\u5742 \u9054\u5f66, \u9577\u6d25 \u660e\u4e45, \u65ed \u3088\u3046, \u5fd7\u667a \u4fca\u4ecb, \u5357\u5bb6 \u7dbe\u6c5f<\/span>, \u5c0f\u6797 \u5e0c, \u7530\u4e2d \u4f38\u54c9, \u6df1\u4e95 \u539f, \u7551\u4e2d \u8c4a<\/span>, \u6b66\u51a8 \u7d39\u4fe1\uff1a\u5206\u5b50\u30b7\u30e3\u30da\u30ed\u30f3\u30b5\u30d6\u30e6\u30cb\u30c3\u30c8X\u3068\u809d\u7d30\u80de\u764c\u4e88\u5f8c\u306e\u95a2\u9023\u306b\u3064\u3044\u3066\u306e\u7814\u7a76, \u7b2c125\u56de \u65e5\u672c\u5916\u79d1\u5b66\u4f1a\u5b9a\u671f\u5b66\u8853\u96c6\u4f1a, \u5bae\u57ce\u770c\u4ed9\u53f0\u5e02<\/td><\/tr>\n
18<\/th>\u7551\u4e2d \u4f73\u5948<\/span>\u5b50\uff0c\u5c71\u672c \u4e07\u7f8e\u5b50<\/span>\uff0c\u5357\u5bb6 \u7dbe\u6c5f<\/span>\uff0c\u5965\u6751 \u9ebb\u7f8e<\/span>\uff0c\u6a0b\u53e3 \u89b3\u4e16\u5b50\uff0c\u5929\u91ce \u9ad8\u5fd7\uff0c\u56db\u5bae \u7fa9\u8cb4<\/span>\uff0c\u5ee3\u5ddd \u6e80\u826f\uff0c\u52a0\u85e4 \u826f\u5e73\uff0c\u7551\u4e2d \u8c4a<\/span>\uff1a\u591a\u6a5f\u95a2\u5171\u540c\u7814\u7a76\u306b\u3088\u308b\u7532\u72b6\u817a\u4e73\u982d\u764c\u306e\u5206\u5b50\u75c5\u7406\u5b66\u7684\u89e3\u6790, \u7b2c114\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a, \u5bae\u57ce\u770c\u4ed9\u53f0\u5e02<\/td><\/tr> <\/tbody>\n\n <\/table>\n\n<\/div>\n\n

\u8868\u306f\u6a2a\u306b\u30b9\u30af\u30ed\u30fc\u30eb\u3057\u3066\u3054\u89a7\u3044\u305f\u3060\u3051\u307e\u3059<\/p><\/div>\n\n\n\n

4. \u4e00\u822c\u6f14\u984c\uff08\u30dd\u30b9\u30bf\u30fc\uff09<\/h3>\n\n\n\n
\n
\n\n \n\n \n\n \n\n <\/colgroup>\n\n \n
No<\/th>\n\n \u5b9f\u7e3e<\/th>\n\n <\/tr>\n\n <\/thead>\n\n
1<\/th>Yokota I<\/span>\uff1aA robust nonparametric algorithm for multi-method calibration of clinical measurements , The 13th Conference of the IASC-ARS, \u30db\u30fc\u30c1\u30df\u30f3<\/td><\/tr>\n
2<\/th>\u5e84\u5b50 \u96c5\u4fca<\/span>\u3001\u6a2a\u7530 \u52f2<\/span>\uff1aTiming of Sample Size Re-estimation in Propensity Score\u2013Weighted Analysis Using Proportional Hazards Models, SAfJR, Amsterdam<\/td><\/tr>\n
3<\/th>Ken Sakushima<\/span>, Koji Fujita, Masashi Aoki, Naoki Atsuta, Makoto Urushitani, Masahisa Katsuno, Osamu Kano, Yuko Kobayakawa, Toshio Shimizu, Akihiro Hirakawa, Yuishin Izumi\uff1aAdvancing Clinical Evaluation Guidelines to Accelerate ALS Neurotherapeutic Development in Japan, American Society for Experimental Neurotherapeutics 2026 Annual Meeting, Bethesda<\/td><\/tr>\n
4<\/th>Naoki Nishimoto<\/span>, Haruka Hakamada<\/span>, Kazumi Yoshinaga<\/span>, Ryo Abe<\/span>, Kaori Kitayama<\/span>\uff1aA Pilot Study of Educational System Review to Keep the Record Against a Problem Employee in Clinical Trial Datacenter., 2025MEDINFO, Taipei, Taiwan<\/td><\/tr>\n
5<\/th>\u767d\u4e95 \u52a0\u4ee3\u5b50<\/span>\u3001\u6751\u4e0a \u611b<\/span>\u3001\u677e\u7530 \u7d14<\/span>\u3001\u9ad8\u6a4b \u9f8d\u6597<\/span>\u3001\u5927\u9ad8 \u548c\u4eba\u3001\u6e21\u908a \u7950\u4ecb<\/span>\u3001\u66fa \u572d\u9f8d<\/span>\u3001\u4f50\u4e45\u5d8b \u7814<\/span>\u3001\u4f50\u85e4 \u5178\u5b8f<\/span>\uff1a\u5317\u6d77\u9053\u5927\u5b66\u75c5\u9662\u306b\u304a\u3051\u308b\u81e8\u5e8a\u7814\u7a76\u3067\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u975e\u5c02\u9580\u8077\/\u672a\u7d4c\u9a13\u8005\u304c\u884c\u3046\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u306e\u8cea\u5411\u4e0a\u3092\u76ee\u6307\u3057\u305f\u652f\u63f4\u6d3b\u52d5, ARO\u5354\u8b70\u4f1a\u7b2c12\u56de\u5b66\u8853\u96c6\u4f1a, \u5343\u8449<\/td><\/tr>\n
6<\/th>\u8352\u5c71 \u771f\u5f13<\/span>\u3001\u6dfa\u91ce \u5343\u6625<\/span>\u3001\u95a2\u53e3 \u771f\u7406<\/span>\u3001\u897f\u6751 \u5343\u4f73\u5b50<\/span>\u3001\u897f\u672c \u5c1a\u6a39<\/span>\u3001\u4f0a\u85e4 \u967d\u4e00<\/span>\u3001\u4f50\u85e4 \u5178\u5b8f<\/span>\uff1a\u30c7\u30fc\u30bf\u30de\u30cd\u30fc\u30b8\u30e3\u306b\u3088\u308bRobotic Process\u3000Automation(RPA)\u3092\u7528\u3044\u305f\u30de\u30cb\u30e5\u30a2\u30eb\u30c1\u30a7\u30c3\u30af\u4f5c\u696d\u306e\u52b9\u7387\u5316\u304a\u3088\u3073\u30c7\u30fc\u30bf\u54c1\u8cea\u5411\u4e0a\u306e\u8a66\u307f, ARO\u5354\u8b70\u4f1a\u3000\u7b2c12\u5b66\u8853\u96c6\u4f1a, \u5343\u8449<\/td><\/tr>\n
7<\/th>\u88b4\u7530 \u9065<\/span>\u3001\u963f\u90e8 \u6dbc<\/span>\u3001\u5409\u6c38 \u548c\u7f8e<\/span>\u3001\u9f4a\u85e4 \u6804\u5b50<\/span>\u3001\u5409\u8c37 \u9678<\/span>\u3001\u5317\u5c71 \u9999\u7e54\u7406<\/span>\u3001\u83c5\u539f \u4eae\u5e73<\/span>\u3001\u897f\u672c \u5c1a\u6a39<\/span>\u3001\u4f0a\u85e4 \u967d\u4e00<\/span>\u3001\u4f50\u85e4 \u5178\u5b8f<\/span>\uff1a\u81e8\u5e8a\u7814\u7a76\u306e\u30c7\u30fc\u30bf\u30de\u30cd\u30fc\u30b8\u30e1\u30f3\u30c8\u696d\u52d9\u306b\u304a\u3051\u308b\u6559\u80b2\u7814\u4fee\u306e\u4f53\u5236\u69cb\u7bc9, \u65e5\u672c\u81e8\u5e8a\u8a66\u9a13\u5b66\u4f1a\u3000\u7b2c17\u56de\u5b66\u8853\u96c6\u4f1a\u7dcf\u4f1a, \u795e\u6238<\/td><\/tr>\n
8<\/th>\u5800\u6c5f \u5948\u7a42<\/span>, \u9ad8\u6a4b \u4fca\u884c<\/span>, \u9577\u672c \u5c1a<\/span>, \u83ca\u6c60 \u3061\u3072\u308d<\/span>, \u7560\u5c71 \u78e8\u91cc\u5b50<\/span>, \u6b66\u7530 \u82b3\u660e<\/span>, \u5bfa\u7530 \u667a\u5b50<\/span>, \u7247\u5ca1 \u7f8e\u7a42<\/span>, \u4f50\u3005\u6728 \u7531\u7d00<\/span>, \u4f50\u85e4 \u5e0c\u7f8e<\/span>, \u51fa\u5408 \u7f8e\u5e06<\/span>, \u8c4a\u7530 \u6709\u5e0c<\/span>, \u6e21\u908a \u7950\u4ecb<\/span>, \u6b66\u672c \u6d69<\/span>, \u4f50\u4e45\u5d8b \u7814<\/span>, \u4f50\u85e4 \u5178\u5b8f<\/span>\uff1a\u5927\u5b66\u796d\u3067\u306e\u30b7\u30fc\u30ba\u7d39\u4ecb\u30a4\u30d9\u30f3\u30c8\u306b\u304a\u3051\u308b\u30a2\u30f3\u30b1\u30fc\u30c8\u8abf\u67fb, ARO\u5354\u8b70\u4f1a\u7b2c12\u56de\u5b66\u8853\u96c6\u4f1a, \u5343\u8449<\/td><\/tr>\n
9<\/th>\u516b\u6728 \u4f38\u9ad8, \u5965\u702c \u6b63\u7d00, \u6797 \u5c1a\u82b3, \u5e83\u7530 \u6c99\u7e54, \u5800\u6c5f \u5948\u7a42<\/span>, \u5409\u7530 \u5e78\u6075, \u677e\u5c71 \u7434\u97f3\uff1a\u60a3\u8005\u3068\u5171\u306b\u5275\u308b\u30d8\u30eb\u30b9\u30b1\u30a2\u306e\u610f\u601d\u6c7a\u5b9a\u306e\u305f\u3081\u306e\u60a3\u8005\u7d4c\u9a13\u30c7\u30fc\u30bf\uff5eGlobal PED\u30ca\u30d3\u30b2\u30fc\u30bf\u30fc\u3092\u6d3b\u7528\u3057\u305fPED\u69cb\u7bc9\u30e2\u30c7\u30eb\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\u3000, \u7b2c46\u56de\u65e5\u672c\u81e8\u5e8a\u85ac\u7406\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a, \u6771\u4eac<\/td><\/tr>\n
10<\/th>\u767d\u9ce5 \u7fd4\u4e5f, \u5ddd\u4e45\u4fdd \u548c\u9053, \u7551\u4e2d \u4f73\u5948\u5b50<\/span>, \u6851\u8c37 \u5c06\u57ce, \u5c0f\u7530 \u7dcf\u4e00\u90ce, \u91ce\u6fa4 \u4fca\u4e00\u90ce, \u7c73\u6751 \u6d0b\u8f1d, \u6749\u6d66 \u8ad2, \u7551\u4e2d \u8c4a<\/span>, \u5742\u672c \u76f4\u54c9\uff1a\u80c6\u9053\u764c\u306b\u304a\u3051\u308bCD73\u767a\u73fe\u3068\u305d\u306e\u9032\u884c\u30fb\u4e88\u5f8c\u3068\u306e\u95a2\u9023\u6027, \u65e5\u672c\u6d88\u5316\u5668\u75c5\u5b66\u4f1a, \u5175\u5eab\u770c\u795e\u6238\u5e02<\/td><\/tr>\n
11<\/th>\u671d\u91ce \u62d3\u53f2, \u7551\u4e2d \u4f73\u5948\u5b50<\/span>, \u7684\u5834 \u4eae, \u7551\u4e2d \u8c4a<\/span>, \u6e21\u5229 \u82f1\u9053\uff1a\u5b50\u5bae\u4f53\u764c\u5206\u5b50\u30b5\u30d6\u30bf\u30a4\u30d7\u5206\u985e\u8a3a\u65ad\u88dc\u52a9\u30b7\u30b9\u30c6\u30e0(POPLAR\u30b7\u30b9\u30c6\u30e0)\u306e\u958b\u767a, \u7b2c67\u56de\u65e5\u672c\u5a66\u4eba\u79d1\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a, \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a<\/td><\/tr>\n
12<\/th>\u8429\u5c3e \u52a0\u5948\u5b50, \u7551\u4e2d \u4f73\u5948\u5b50<\/span>, \u56db\u5bae \u7fa9\u8cb4<\/span>, \u5965\u6751 \u9ebb\u7f8e<\/span>, \u5357\u5bb6 \u7dbe\u6c5f<\/span>, \u677e\u5cf6 \u7531\u4f73, \u67cf \u548c\u54c9, \u5927\u6771 \u5143\u5c31, \u6728\u4e0b \u4e00\u90ce, \u9ad8\u6a4b \u5c07\u4eba, \u7551\u4e2d \u8c4a<\/span>\uff1aHR\u967d\u6027HER2\u9670\u6027\u4e73\u764c\u306e\u65e9\u671f\u307e\u305f\u306f\u6669\u671f\u518d\u767a\u306b\u304a\u3051\u308b\u7db2\u7f85\u7684\u907a\u4f1d\u5b50\u767a\u73fe\u89e3\u6790\u3092\u7528\u3044\u305f\u691c\u8a0e, \u7b2c33\u56de\u65e5\u672c\u4e73\u764c\u5b66\u4f1a\u7dcf\u4f1a, \u6771\u4eac\u90fd\u65b0\u5bbf\u533a<\/td><\/tr>\n
13<\/th>\u56db\u5bae \u7fa9\u8cb4<\/span>, \u6751\u5c71 \u7406\u5b50<\/span>, \u7530\u4e2d \u4f51\u5b9f<\/span>, \u4e0b\u9053 \u771f\u7531\u7f8e<\/span>, \u5357\u5bb6 \u7dbe\u6c5f<\/span>, \u77f3\u7530 \u88d5\u5b50, \u82e5\u6797 \u5065\u4eba, \u5916\u4e38 \u8a69\u91ce, \u7551\u4e2d \u8c4a<\/span>, \u7551\u4e2d \u4f73\u5948\u5b50<\/span>\uff1a\u9023\u7d9a\u8fc5\u901f\u81ea\u52d5\u56fa\u5b9a\u5305\u57cb\u88c5\u7f6e\u306b\u3088\u308a\u51e6\u7406\u3055\u308c\u305f\u7d44\u7e54\u691c\u4f53\u306e\u6838\u9178\u54c1\u8cea\u306b\u95a2\u3059\u308b\u691c\u8a0e, \u7b2c114\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a, \u5bae\u57ce\u770c\u4ed9\u53f0\u5e02<\/td><\/tr>\n
14<\/th>\u5357\u5bb6 \u7dbe\u6c5f<\/span>, \u7551\u4e2d \u4f73\u5948\u5b50<\/span>, \u5c71\u672c \u4e07\u7f8e\u5b50<\/span>, \u5965\u6751 \u9ebb\u7f8e<\/span>, \u56db\u5bae \u7fa9\u8cb4<\/span>, \u7530\u4e2d \u4f38\u54c9, \u5ee3\u5ddd \u6e80\u826f, \u52a0\u85e4 \u826f\u5e73, \u7551\u4e2d \u8c4a\uff1a\u7532\u72b6\u817a\u764c\u306b\u304a\u3051\u308b\u30c9\u30e9\u30a4\u30d0\u30fc\u5909\u7570\u306e\u514d\u75ab\u7d44\u7e54\u5316\u5b66\u7684\u691c\u51fa\u306b\u95a2\u3059\u308b\u691c\u8a0e, \u7b2c114\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a, \u5bae\u57ce\u770c\u4ed9\u53f0\u5e02<\/td><\/tr>\n
15<\/th>\u671d\u91ce \u62d3\u53f2, \u7551\u4e2d \u4f73\u5948\u5b50<\/span>, \u7684\u5834 \u4eae, \u7551\u4e2d \u8c4a<\/span>, \u6e21\u5229 \u82f1\u9053\uff1a\u5b50\u5bae\u4f53\u764c\u5206\u5b50\u30b5\u30d6\u30bf\u30a4\u30d7\u5206\u985e\u8a3a\u65ad\u88dc\u52a9\u30b7\u30b9\u30c6\u30e0(POPLAR\u30b7\u30b9\u30c6\u30e0)\u306e\u691c\u67fb\u6027\u80fd\u306b\u95a2\u3059\u308b\u691c\u8a0e, \u7b2c77\u56de\u65e5\u672c\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a, \u5ca1\u5c71\u770c\u5ca1\u5c71\u5e02<\/td><\/tr>\n
16<\/th>\u5c0f\u6797 \u6b63\u5e78, \u76f8\u5c71 \u5065, \u7551\u4e2d \u4f73\u5948\u5b50<\/span>, \u7551\u4e2d \u8c4a<\/span>, \u5c71\u672c \u8449\u4e00, \u5fd7\u667a \u4fca\u4ecb, \u85e4\u5c45 \u52c7\u8cb4, \u85e4\u597d \u76f4, \u65ed \u3088\u3046, \u9577\u6d25 \u660e\u4e45, \u5ddd\u6751 \u5178\u751f, \u6e21\u8fba \u6b63\u660e, \u5f8c\u85e4 \u4e86\u4e00, \u67ff\u5742 \u9054\u5f66, \u6df1\u4e95 \u539f, \u6b66\u51a8 \u7d39\u4fe1\uff1a\u809d\u7d30\u80de\u764c\u306b\u304a\u3051\u308b\u6709\u6a5f\u30a2\u30cb\u30aa\u30f3\u30c8\u30e9\u30f3\u30b9\u30dd\u30fc\u30bf\u30fcOATP1B3\u306e\u7d30\u80de\u5185\u5c40\u5728\u5225\u767a\u73fe\u89e3\u6790, \u7b2c125\u56de \u65e5\u672c\u5916\u79d1\u5b66\u4f1a\u5b9a\u671f\u5b66\u8853\u96c6\u4f1a, \u5bae\u57ce\u770c\u4ed9\u53f0\u5e02<\/td><\/tr>\n
17<\/th>\u56db\u5bae \u7fa9\u8cb4<\/span>, \u9ad8\u5730 \u7950\u8f14, \u9375\u8c37 \u685c\u5b50, \u77f3\u6bdb \u5d07\u4e4b, \u7551\u4e2d \u4f73\u5948\u5b50<\/span>, \u7551\u4e2d \u8c4a<\/span>, \u9ad8\u91ce \u91cd\u7d39, \u5927\u585a \u5c06\u4e4b, \u6c60\u7530 \u7d14\u4e00\u90ce, \u5cb8\u672c \u5145\uff1a\u30c7\u30ad\u30b5\u30e1\u30bf\u30be\u30f3\u306f\u3001ECM1\u3068KRT6A\u306e\u767a\u73fe\u8a98\u5c0e\u306b\u3088\u308a\u81b5\u81d3\u304c\u3093\u306e\u816b\u760d\u9032\u884c\u3068\u5316\u5b66\u7642\u6cd5\u8010\u6027\u3092\u5f15\u304d\u8d77\u3053\u3059, \u7b2c84\u56de\u65e5\u672c\u764c\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a, \u77f3\u5ddd\u770c\u91d1\u6ca2\u5e02<\/td><\/tr> <\/tbody>\n\n <\/table>\n\n<\/div>\n\n

\u8868\u306f\u6a2a\u306b\u30b9\u30af\u30ed\u30fc\u30eb\u3057\u3066\u3054\u89a7\u3044\u305f\u3060\u3051\u307e\u3059<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"

2025\u5e74\u5ea6 1. \u8ad6\u6587\u30fb\u8457\u66f8 No \u5b9f\u7e3e 1 Tarisawa M, Matsushima M, Kudo A, Nomura T, Uwatoko H, Shirai S, Takahashi-Iwata I, Sa […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":62,"menu_order":39,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/helios.huhp.hokudai.ac.jp\/crmic\/wp-json\/wp\/v2\/pages\/83"}],"collection":[{"href":"https:\/\/helios.huhp.hokudai.ac.jp\/crmic\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/helios.huhp.hokudai.ac.jp\/crmic\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/helios.huhp.hokudai.ac.jp\/crmic\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/helios.huhp.hokudai.ac.jp\/crmic\/wp-json\/wp\/v2\/comments?post=83"}],"version-history":[{"count":21,"href":"https:\/\/helios.huhp.hokudai.ac.jp\/crmic\/wp-json\/wp\/v2\/pages\/83\/revisions"}],"predecessor-version":[{"id":4461,"href":"https:\/\/helios.huhp.hokudai.ac.jp\/crmic\/wp-json\/wp\/v2\/pages\/83\/revisions\/4461"}],"up":[{"embeddable":true,"href":"https:\/\/helios.huhp.hokudai.ac.jp\/crmic\/wp-json\/wp\/v2\/pages\/62"}],"wp:attachment":[{"href":"https:\/\/helios.huhp.hokudai.ac.jp\/crmic\/wp-json\/wp\/v2\/media?parent=83"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}